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Abstract 
 
Tuberculosis (TB) is a public health priority in urban cities of high income countries 
such as the UK, where the local incidence can be several times that of the national 
incidence. A large dataset of 63,620 individuals registered at a single centre in 
Birmingham, UK captured all TB treatment episodes (active disease and latent 
infection) and contained individual level detail on contacts of TB cases from 1980 to 
2011. Exploratory analysis of the pseudonymised research dataset revealed clusters 
of individuals presenting as cases and contacts through time. Repeated cases 
originated from the pool of known individuals treated for active or latent TB with a 
probability of 1.5% at five years and 2.7% at ten years, but routine recording of 
latent TB treatment episodes is not widespread to estimate the future burden of 
retreatment TB. When repeated contacts were examined, their probability of being 
diagnosed as a case was twice that of non-repeated contacts (3.9% versus 1.6% for 
active disease and 10.7% versus 3.7% for latent infection) at one year. Contact 
repetition should be recognised but consistent recording of patient identity is lacking. 
In further evaluation of the role of contact structure in case detection, only the 
eigenvector centrality (connections to other highly scoring individuals) was 
associated with at least one case detection in the local network. Because networks 
were viewed from a static approach and network metrics may reflect effect rather 
than cause of the contact tracing process, further interpretation was difficult. 
However network visualisation identified a large cluster of 3,148 individuals, who 
entered the dataset at all times in the study period, that were linked through a 
superspreading event. Evaluating transmission was limited by a small sample of 
patients with mycobacterial repetitive unit-variable number tandem repeats (MIRU-
VNTR) typing but data available suggested that the superspreading event was nested 
within a risk network rather than a transmission network. 
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1 Introduction 
 
“If fully used the combination of diagnostic facilities and 
effective chemotherapy now available in this country could result 
in tuberculosis becoming truly rare in England and Wales by the 
end of this century; on present trends there are likely to be a few 
hundred new notification of tuberculosis in the year 2000 A.D.” 
(Springett, 1972) 
 
 
1.1 Overview 
Tuberculosis (TB) has been present throughout human history, from its detection in 
Egyptian mummies (Cave, 1939; Nerlich et al., 1997) to the epidemic that swept 
across Europe during the industrial revolution (Dubos and Dubos, 1952). Since the 
turn of the 20th century there has been declining TB incidence in the Western world 
(Long et al., 1999; Raviglione et al., 1993; Schneider and Castro, 2003) as illustrated 
by historical TB data in England and Wales in Figure 1. This trend prompted 
predictions that TB would soon be a disease of the past (Springett, 1972). 
 
The 1990s saw a resurgence in cases with multiple factors such as the HIV epidemic, 
increased migration and downgrading of TB control programs thought to be 
contributory (Grange and Zumla, 2002; Snider, 1997). In 1993 TB was declared a 
global health emergency (WHO Global Tuberculosis Programme, 1994) and yet still  
today it is the single largest cause of death worldwide from an infectious disease 
with an estimated 1.3 million deaths out of the 10.4 million people developing active 
disease in 2016 (World Health Organization, 2017).
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!Figure!1.!TB!incidence!rates!in!England!and!Wales,!1913!to!2016.!Number!of!cases!per!year!was!taken!from!historical!case!notification!data!(Public!Health!England,!2017)!and!population!estimates!extrapolated!from!census!data!(Office!for!National!Statistics,!2017!and!University!of!Portsmouth,!2017).!!
 
1.2 The global plan to end TB 
Global targets for TB elimination (defined as less than one case of TB disease per 
million population per year) by 2050 were set in 2010 (World Health Organization 
and Stop TB Partnership, 2010). Concerted efforts in active case management with 
early diagnosis and provision of directly-observed therapy in low and middle-income 
countries has resulted in approximately a 2% yearly decline in incidence, but this 
reduction rate needs to double for the incidence trajectory to reach the milestone of 
less than 85 cases per 100,000 per year by 2020 set by the World Health 
Organization (World Health Organization, 2017). Ten very high burden countries 
with large estimated proportion of untreated cases (India, China, the Russian 
Federation, Indonesia, the Philippines, Pakistan, Nigeria, Ukraine, Myanmar and 
Uzbekistan) are important targets for improvement (World Health Organization, 
2017). 
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1.3 TB in low incidence countries 
Low incidence countries (<100 cases per million population) have the greatest 
potential to reach TB elimination. In these settings TB is heterogeneously 
distributed, with the burden of disease in urban areas (Hayward et al., 2003; Oren et 
al., 2011), amongst migrants (Cain et al., 2007; Gaudette and Ellis, 1993; Rose et 
al., 2001), the poor (Bhatti et al., 1995; Hawker et al., 1999) and other 
disadvantaged groups such as homeless persons, prisoners and substance misusers 
(Haddad et al., 2005; Story et al., 2007). Thus the epidemiology can be characterised 
by concentration in hard-to-reach risk groups and a low rate of transmission in the 
general population, sporadic outbreaks and active disease mainly generated by latent 
infection acquired remotely rather than recently/locally (Lonnroth et al., 2015). This 
epidemiological profile has been referred to as TB in big cities, a unique situation 
that requires innovative responses to enable transition into the pre-elimination phase 
(de Vries et al., 2014). Birmingham, UK, falls into this category. 
 
In 2014 the World Health Organization identified 331 countries with a national TB 
incidence of <100 cases per million to energise the progress towards TB pre-
elimination in these countries (Lonnroth et al., 2015). Some cities in these low 
incidence countries however have up to twice the national incidence rate (de Vries et 
al., 2014). 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                
1 Australia, Austria, Bahamas, Belgium, Canada, Costa Rica, Cuba, Cyprus, Czech 
Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, 
Jamaica, Jordan, Luxembourg, Malta, Netherlands, New Zealand, Norway, Puerto Rico, 
Slovakia, Slovenia, Sweden, Switzerland, United Arab Emirates, United States of America, 
West Bank and Gaza Strip !
Chapter 1. Introduction  
 
 17 
1.4 TB control 
TB transmission relies on inhalation of airborne droplet nuclei containing 
Mycobacterium tuberculosis (Loudon and Roberts, 1967; Riley et al., 1995), a slow 
growing intracellular bacilli that has a lipid-rich cell wall and outer membrane that 
acts as an effective barrier to phagocytosis and antimicrobials (Osoba, 2004). 
Infection depends first on exposure to sources emitting infectious droplet nuclei. The 
pool of infectious cases in the community, duration of infectiousness and patterns of 
interactions between susceptible and infectious individuals are therefore primary 
drivers of observed TB epidemiology (Figure 2). Secular trends such as 
improvements in living standards and social conditions were widely credited with 
the sharp decline in TB incidence at the turn of the 20th century by reducing the 
number of successful transmissions, or effective contact rate, even prior to the 
availability of effective drug treatment (Vynnycky and Fine, 1999). However early 
diagnosis and treatment of active disease to reduce community exposure to TB 
remains at the core TB control and is the dominant intervention employed in the 
Stop TB Strategy (World Health Organization and Stop TB Partnership, 2006). 
 
Infection following exposure is dependent on the intensity of the bacillary load 
(O’Shea et al., 2014; Riley et al., 1995) and host immune response, particularly 
macrophage function (Schluger and Rom, 1998) (Figure 2). Interventions to modify 
these factors could include prioritisation of contacts of more infectious cases (e.g. 
sputum smear-positive cases), and attention to ventilation in congregate settings 
where TB is endemic (Taylor et al., 2016). Thereafter risk of progression to active 
disease, whether infectious or non-infectious, is higher within the first few years of 
infection (Sloot et al., 2014; Trauer et al., 2016), impaired host immune response 
(Harries, 1990; Keane et al., 2001) and pathogen virulence (Newton et al., 2006; 
Yang et al., 2012) (Figure 2). These factors are less amenable to epidemiologic 
control. However, chemotherapy for latent infection is protective against future 
disease and infectiousness (Smieja et al., 2000). Reducing the reservoir of infection 
by finding and treating individuals with latent infection is an essential requirement 
for TB elimination (Dye et al., 2013). 
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!Figure!2.!Schematic!for!epidemiologic!basis!of!TB!control,!adapted!from!Rieder!(1995!and!1999).!!!
 
 
1.5 Control strategy in England 
England had one of the highest rates of tuberculosis among industrialised countries 
(14.4 per 100,000 per year) in 2012 (European Centre for Disease Prevention and 
Control/WHO Regional Office for Europe, 2018). The problem was attributed to 
relatively larger number of migrants from high TB burden countries with over 70% 
of TB cases diagnosed in the foreign-born (Gilbert et al., 2009), variable 
implementation of migrant screening programmes (Pareek et al., 2011) and 
inadequate numbers of specialist staff (Bothamley et al., 2011).  
 
Recently the two decades of increasing TB incidence in England has reversed. Since 
2012, an 8% decline in the number of cases annually has been observed with the 
annual incidence dropping to 10.2 per 100,000 in 2016 (Public Health England, 
2017b). A recent analysis has suggested declines in TB rates in all populations (UK 
and non UK-born (except EU countries) and regardless of time since arrival in the 
UK) contributed more to this trend rather than change in migration patterns (Thomas 
et al., 2018). Interventions that may have contributed to the incidence decline 
include provision of outreach services for hard-to-reach groups (Daly et al., 2016; Jit 
et al., 2011) and strengthened governance of TB control activities (Anderson et al., 
2014). 
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Another major control strategy is pulmonary TB screening in visa applicants from 
high incidence countries (≥40 per 100,000) prior to UK entry (Public Health 
England, 2017c). This was rolled out in 2014 following successful pilot studies from 
2005. In 2016, the incidence of pulmonary TB observed was 100 per 100,000 
applicants (Public Health England, 2017c). 
 
Following on from the pre-entry screening programme a national tuberculosis 
strategy for England was published in 2015 (Public Health England, 2015). This 
signaled renewed political commitment to the TB elimination agenda and provision 
of leadership and funding. A major component of this strategy is the establishment 
of seven multi-agency TB control boards (Figure 3) to deliver co-ordinated TB 
control activities within each area. 
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!Figure!3.!Geographic!distibution!of!TB!control!boards!in!England!(which!are!aligned!to!Public!Health!England!centres)!and!2016!case!notification!rates!by!board.!Image!from!Public!Health!England,!Tuberculosis!in!England!2017!report!(London:!Public!Health!England,!2017).!!
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Figure 1.5: TB case notifications and rates by TB control board3, England, 2016  
 
 
 
 
 
  
                                            
 
3
 Th  TB Contr l Boards (TBCBs) are aligned with PHEC boundaries other than North East and the Yorkshire and t e Humber 
PHECs, which together form the North East, Yorkshire and Humber TBCB, and the South East and South West PHECs, which 
together form the South of England TBCB 
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1.6 Modern contact investigation strategies 
In low-incidence countries active case finding through contact investigation is a 
principal activity of TB control programmes. The prevailing approach is the 
concentric circle or “stone-in-pond” method. The underlying principle is that those 
in closest physical proximity (i.e. shared air space over the most time) to an 
infectious case are most likely to be infected, and if they are not then the yield from 
contact tracing those less close is minimal (Veen, 1992). This approach is pragmatic 
particularly when dealing with outbreaks in congregate settings. 
 
The advent of a polymerase chain reaction-based test to enumerate variable number 
tandem repeats in the mycobacterial genome and distinguish relatedness has made 
universal genotyping routine (Bolotin et al., 2010; Lambregts-van Weezenbeek et 
al., 2003; Public Health England, 2014). Genotyping has been useful in highlighting 
casual contact/location-based transmission, among other things such as detection of 
false-positive TB laboratory results (Frieden et al., 1996). Thus there is an increasing 
interest in utilising network data to identify relevant contacts (Cook et al., 2012). 
Post hoc examination of location data after a molecular outbreak has been helpful in 
identifying the congregate setting where transmission occurred (Gardy et al., 2011). 
However lack of data systems that could utilise prospectively collected location data 
in such a way is a limiting factor. 
 
Geospatial scanning has also been proposed as a further adjunct to identify hotspots 
of TB in conjunction with genotyping information (Moonan et al., 2012; Smith et 
al., 2017). These hotspots could be targets for intervention but to date no practical 
application of its utility in the field has been demonstrated. 
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1.7 The Birmingham TB register 
Birmingham is the second most populous UK city with approximately 1.1 million 
residents in 2016 (Office for National Statistics, 2017) and is among five UK cities2 
with a high TB burden (≥40 per 100,000 during 2006-2008) (Kruijshaar et al., 2012). 
Therefore outside of London, the Birmingham TB Control Board has a significant 
task in the elimination agenda. 
 
Case reporting to the national surveillance database for the city, and the adjacent 
urban borough of Solihull, is done centrally from the Birmingham Chest Clinic, a 
purpose-built outpatient facility for TB and other lung diseases in operation since 
1932. National surveillance reporting was paper-based until 2008/9, but a local 
electronic database of case notifications and contact investigation for clinical use has 
been in existence at the Birmingham Chest Clinic since 1980. 
 
This comprehensive population level data spanning three decades has never been 
systematically analysed. While subject to drawbacks such as reliability of data 
quality the Birmingham TB Register presents a unique opportunity to investigate the 
local epidemiology and inform service planning.  Specifically, the large amount of 
TB contact data linked to cases may generate new knowledge and understanding 
about the transmission of TB in this setting. A general aim of the research in this 
thesis was to go beyond traditional demographic and clinical factors to prioritise 
contacts and communities, and identify innovative criteria based on contact patterns.  
 
 
 
 
 
 
 
 
 
                                                2 The other cities are London, Leicester, Slough and Luton 
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1.8 Rationale and research objectives 
TB in big cities is a particular challenge and requires setting-specific research to 
understand its epidemiology. The availability of this large electronic register of cases 
and contacts in Birmingham, a high-burden city can be exploited for this purpose. 
Implementation of modern approaches to contact investigation as described in 
section 1.6 will require increased resources but their feasibility for routine use needs 
further study. Findings could inform priorities and resource planning not only for the 
local TB Board, but are likely transferable to other settings of urban TB. 
 
Research objectives are outlined separately in each chapter of the thesis. 
 
1.9 Thesis outline 
The next chapter is an overview of the Birmingham TB Register’s background, data 
collection methods and conversion into the research dataset. The subsequent five 
chapters explore the data set in different ways. Chapter 3 is a time-to-event analysis 
of recurrent TB treatment episodes. Chapter 4 investigates transitions between being 
named as a case and being named as contact in the dataset using competing risks 
methodology. Chapter 5 is a descriptive analysis of the network formed by cases and 
contacts combined. Chapter 6 is a further descriptive analysis of a very large group 
of connected cases and contacts in the network. Finally chapter 7 is an exploratory 
investigation of how clusters of cases and contacts grow in size using survival 
methods and an individual growth model. 
 
Molecular epidemiology based on mycobacterial repetitive unit-variable number 
tandem repeats (MIRU-VNTR) was available for a subset of cases and is explored 
throughout the chapters where relevant. 
 
Although location/geographic data was available for cases and contacts in the dataset 
this theme is not investigated in this thesis.
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2 Background to the research dataset 
 
2.1 Introduction 
 
The data used throughout this research is routine clinical information contained in a 
database owned and managed by the Heart of England NHS Foundation Trust, a 
large organisation that runs general and specialist clinical services in the West 
Midlands region of the UK. This chapter will describe the historical background to 
the clinical database, how clinical data was collected and known temporal changes 
that have occurred, data structure and finally methods used to create the research 
dataset. 
 
2.2 The Birmingham Tuberculosis Register 
There has been a long history of routinely collected data related to tuberculosis (TB) 
at Birmingham Heartlands Hospital, part of the Heart of England NHS Foundation 
Trust. The municipal sanatorium for the city of Birmingham was established near the 
present day hospital site following legislation entrusting sanitation and control of 
infectious diseases to the local authority (Public Health Act, 1875). While initially an 
isolation facility for smallpox cases due to its location away from the general public 
at the time, in 1895 two per thousand population died of tuberculosis leading to the 
site evolving into a TB sanatorium by 1910 (Ayres et al., 1995). 
 
Prior to statutory requirement to notify cases of clinical tuberculosis in 1911 (Public 
Health (Tuberculosis) Regulations, 1911), reporting was voluntary but encouraged 
by a payment for each case notified. Birmingham City Council recognised early the 
importance of establishing how many cases they had to deal with in order to control 
TB and introduced mandatory notification as early as 1904 (Ayres et al., 1995). 
Hand-written registers for all TB cases within the city boundaries dating back to 
1903 are in hospital archives detailing name, date of birth, sex, address, date of 
admissions and discharges or death (Martin Dedicoat 2017, personal communication, 
2 October). 
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Early records in the Birmingham TB register collected the minimum data necessary 
to inform trend analyses and public health action. The hospital continued to maintain 
the city-wide register following nationalisation in 1948 (National Health Service 
Act, 1946). In 1978, five-yearly national TB surveys were initiated with more 
detailed clinical and demographic data collected (MRC Tuberculosis and Chest 
Diseases Unit, 1980). This additional information was gradually incorporated into 
the Birmingham TB register to enable reporting. From 1999 onwards, the Health 
Protection Agency (now Public Health England) established an enhanced 
tuberculosis surveillance (ETS) system in England and Wales, which routinely 
records additional demographic, clinical and microbiological information (Public 
Health England, 2013). The Birmingham TB register now mirrors ETS data to 
streamline upstream reporting. 
 
2.3 The clinical database 
The Birmingham TB register became digital in 1980. With just over 600 TB cases 
treated at the Birmingham Chest Clinic (an outpatient centre for tuberculosis care 
established by city council in 1933 and absorbed into the national health service as 
part of the Heart of England NHS Foundation Trust) in 1980, the need for an 
electronic tool to co-ordinate clinical appointments for case management was 
evident. Dr John Innes, a chest physician at the Birmingham Chest Clinic wrote a 
relational database in dBase for this purpose (Martin Dedicoat 2017, personal 
communication, 2 October). Because patients treated for latent TB infection also 
required clinical follow-up, they were included the database. From 1987 onwards, 
the large numbers of TB contacts assessed were also entered to track management 
and follow-up. Contacts had less demographic and clinical data recorded compared 
to cases, but linkage to index cases was preserved and type of relationship, where 
known, was entered. No other known UK dataset contains information about latent 
TB cases and TB contacts over this time frame. 
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Thus while historically a surveillance register, the electronic Birmingham TB 
register is primarily an administrative tool that networks with other NHS clinical 
systems, for example patient registration data and appointment bookings. It also 
enables outcomes assessment that informs commissioning evaluation locally. All 
data were collected prospectively in the course of normal healthcare provision by the 
clinical team. 
 
Local case notification data continues to be reported nationally through the web-
based ETS. Data from the Birmingham TB register is entered separately into ETS 
because within Public Health England’s national database system no data flow to or 
from NHS clinical systems are possible. 
 
2.4 Routine data collection 
 
2.4.1 Catchment population  
The electronic Birmingham TB register holds records of all cases of active TB, 
treated latent TB infection and TB contacts residing within the Birmingham and 
Solihull local authority boundaries since 1980 (Figure 4). The geographic size of the 
area is approximately 167 square miles with a population of 1.34 million in 2016 
(Office for National Statistics, 2017). There have been minor additions to the 
catchment boundaries in 1982 (borough of Sutton Coldfield), 1995 (Frankley and 
Kitwell estates in Bromsgrove) and 2004 (New Hall Ward/Walmley area). 
 
Individuals moving in to the area on TB therapy after an initial diagnosis elsewhere 
may not be entered into the register if they did not attend TB services locally i.e. 
they chose to continue follow-up with the care provider at their previous address. 
Individuals who were diagnosed and started on TB therapy in the study area but who 
subsequently moved out were included and their transfer to a different care provider 
was recorded as an outcome in the register. 
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!Figure!4.!Geographical!area!corresponding!to!local!authority!boundaries!included!in!the!Birmingham!TB!register!shaded!in!yellow.!Numbers!denote!the!threeVyear!average!(2014V2016)!incidence!rates!for!each!local!authority!(Public!Health!England,!2017a).!
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Figure 1. Geographical area corresponding to local authority boundaries included in t e Birmingham TB 
register shaded in yellow. Numbers denote the three-year average (2014-2016) incidence rates for each local 
authority (Public Health England, 2017). 
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2.4.2 Case table 
All patients treated for active or latent TB (both culture-confirmed and unconfirmed) 
residing in the catchment area were entered into a single case table. Data fields 
included in the case table, and completeness of data entry, are detailed in Appendix 
1.1. 
 
2.4.2.1 Active TB cases 
Notification of active TB cases for entry into the Birmingham TB register was 
received from treating clinicians or the laboratory following culture confirmation. 
The Birmingham Chest Clinic has historically held all city-wide notifications of TB 
since statutory requirements for reporting clinical disease began. Thus the case table 
likely reflects accurate ascertainment of all active TB cases in the area, including 
post-mortem diagnoses which are notified by the laboratory if culture positive. Post-
mortem cases with only histological diagnoses may have escaped registration and 
statutory notification. Cases that were subsequently found to have an alternative 
diagnosis and denotified were retained in the case database, but could be identified 
as denotified. 
 
There were 300 to 400 case notifications of TB disease annually (Figure 5). Annual 
incidence declined from 50 per 100,000 (95% confidence interval, CI 46, 55) in 
1980 to a low of 21 per 100,000 (95% CI 18, 23) in 1988. In the next decade the 
incidence fluctuated between 20 to 30 per 100,000 but since late 1990s the incidence 
has been trending upwards reaching a peak of 41 per 100,000 (95% CI 37, 44) in 
2009 (Figure 6). 
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            Figure!5.!Number!of!TB!disease!case!notifications!in!the!Birmingham!TB!Register,!1980!to!2011.!
 
                  Figure!6.!Annual!TB!disease!incidence!in!Birmingham!and!Solihull,!1980!to!2011.!Population!estimates!were!extrapolated!from!census!data!(Office!for!National!Statistics,!1997;!2000;!2005;!2016).!Vertical!bars!denote!95%!confidence!interval!calculated!assuming!a!Poisson!distribution.!!!!
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2.4.2.2 Latent TB cases 
Latent cases are not statutorily reported but as all treatment monitoring in the 
community were undertaken by TB nurses based at the Birmingham Chest Clinic, 
the case database likely includes all treated latent TB cases in the area. 
 
The case database does not however reflect complete ascertainment of the burden of 
latent TB infection. Firstly individuals found to have latent infection, but were not 
given or declined treatment, were not recorded. Secondly testing for latent TB 
infection was only offered to contacts in certain age groups. Up to 2006 only 
children under 16 were assessed for latent infection. Locally latent TB testing was  
expanded to those aged 35 and under from around 2007 (Zeitun Afzal 2014, personal 
communication, 12 April). 
 
Where testing was offered this was largely using tuberculin skin testing. Reaction of 
grade 3 or 4 in BCG-vaccinated individuals or grade 2 in unvaccinated individuals 
following a Heaf test was considered positive.  Mantoux testing largely replaced 
Heaf testing in the late 2000s. Induration of 15mm or more for BCG-vaccinated 
individuals or 6mmm or more for non-vaccinated individuals were considered 
positive. At these cut-offs the estimated sensitivity and specificity of the tuberculin 
skin testing is high for BCG-vaccinated children  (up to age 15) (90% to 100% and 
83% to 96% respectively) but lower for BCG-vaccinated children (66% to 87% and 
79% to 89%) (Seddon et al., 2016). In adults sensitivity is similar but specificity 
ranges from 35% to 79% in vaccinated adults (Pai et al., 2008). From 2011 onwards, 
positive Mantoux tests were confirmed with interferon gamma release assays before 
definitive diagnosis. This assay has high specificity (86% to 100%) (Pai et al., 2008). 
 
Up to 2012 almost all active case finding efforts were concentrated among TB 
contacts with only ad hoc cases found through screening in other at risk groups. 
Hence the majority of latent cases were diagnosed as a result of exposure to an index 
case.  
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There were between 50 to 100 cases of treated latent TB infection annually in the 
study area (Figure 7). The numbers treated have increased dramatically since 2000s, 
with an incidence of 9 per 100,000 in 2000 (95% CI 7, 11) rising to 23 per 100,00 in 
2011 (95% CI 20, 25)  (Figure 8). 
     Figure!7.!Number!of!treated!latent!TB!infection!case!notifications!in!the!Birmingham!TB!register,!1980!to!2011.!
              Figure!8.!Annual!treated!latent!TB!case!incidence!in!Birmingham!and!Solihull,!1980!to!2011.!Population!estimates!were!extrapolated!from!census!data!(Office!for!National!Statistics,!1997;!2000;!2005;!2016).!Vertical!bars!denote!95%!confidence!interval!calculated!assuming!a!Poisson!distribution.!!!!
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2.4.3 Contact table 
Contact tracing has always been performed in Birmingham and Solihull but contacts 
were only included in the TB register, in a separate table from cases, from 1987 
onwards. In brief, each TB case was interviewed by a TB nurse within five working 
days of their diagnosis. The interview was usually undertaken within the home and 
occasionally in the clinic. Cases were asked to volunteer the names of individuals 
they had regular contact with during and 3 months prior to the infectious period. 
Named contacts residing at the same residential address as the index case were 
categorised as household contact. Those residing at a different address were 
categorised as a close contact. Contacts who required tracing due to exposure at a 
congregate setting e.g. workplace or school, but not named as contacts at interview, 
were categorised as casual contacts. For non-infectious cases only household 
members were contact traced. 
 
Collection of casual contact data was done on a case-by-case basis. If an infectious 
case was known to have regular attendance within an indoor congregate setting (e.g. 
school or workplace) a risk assessment was done by the clinical and public health 
team. This usually involved a visit to the congregate setting location. Casual contacts  
were then sought depending on perceived infectiousness of the index case, e.g. 
known transmission to household and contacts already examined, duration of 
symptoms, site of TB especially if laryngeal, duration of infectious period and 
vulnerability of individuals exposed at the congregate setting. This process was 
subjective but directed by established guidance (National Institute for Health and 
Clinical Excellence, 2016). Sequential contact tracing was usually the norm, starting 
with those in closest proximity to a case e.g. sharing a class and progressing to those 
that are presumed to have less intimate contact e.g. being in the same class year but 
not sharing a class.  
 
Contacts had their index case details recorded in the contacts table. Occasionally, 
contacts were referred in from TB programmes outwith Birmingham because their 
index case resided there while the contact resided in the Birmingham catchment area.  
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Each contact was screened for symptoms by interview and further evaluated for 
latent TB (see section 1.4.2.2). Contacts who were uncontactable, refused screening 
or deemed not to need screening by the treating physician would still be entered in 
the contact table and incomplete follow-up documented. 
 
A contact diagnosed with active or latent TB would be entered in both the contact 
and case tables. Data fields in the contact table are detailed in Appendix 1.2.  
 
The median number of household and close, non-household contacts named by a TB 
case was between 1 and 3 individuals (Figure 9). Less contacts were named over 
time (median 2, interquartile range, IQR 0 – 7 in 1995 compared to 2, IQR 0 – 4 in 
2010). 
 
                Figure!9.!Number!of!household!and!close!(nonVhousehold)!contacts!named!by!TB!cases,!1980!to!2011.!
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2.4.4 Demographic and clinical data 
Ethnicity and birthplace were self-reported. Address was also self-reported; multiple 
addressed were not entered. However school and work location was recorded if 
known but this is not uniformly elicited (Catherine Brown, 2013, personal 
communication, 22 February).  Social risk factors such as homelessness, alcohol 
history, smoking history and prison history were not always known and variably 
entered into the database. Medical history was also not usually recorded except when 
HIV co-infection was present (< 1% of cases per year). 
 
2.4.5 Laboratory methods 
All microbiological specimens were processed at Public Health England Regional 
Centre for Mycobacteriology, Birmingham. Drug susceptibility testing was 
performed using the resistance ratio or proportion method (Drobniewski et al., 
2007). Since 2003, strain typing by 15-loci mycobacterial repetitive unit-variable 
number tandem repeats (MIRU-VNTR) was done prospectively on all culture-
positive specimens. This typing method uses the polymerase chain reaction to 
quantify the number of repetitive sequences, or tandem repeats, at multiple 
independent genetic loci across the M. tuberculosis genome (Barnes and Cave, 2003; 
P Supply et al., 2001). The number of repeats at each loci is variable and 
distinguishes relatedness between strains.  
 
Typing using 12 loci was shown to be very stable and reproducible, but did not 
provide sufficient differentiation for isolates in the Beijing clade (Kremer et al., 
2004; Supply et al., 2006). Additional VNTR loci can provide higher resolution, and 
subsequently 24-loci MIRU-VNTR typing has become the international standard 
(Nikolayevskyy et al., 2016; Supply et al., 2006). From 2010 onwards, 24-loci 
typing became routine in Birmingham. Selected isolates prior to 2003 were re-typed 
retrospectively if they potentially belonged to a cluster, defined as having 2 or more 
patients with indistinguishable typing at all loci, with up to one missing loci allowed 
(Public Health England, 2014).  
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Typing data, which consisted of concatenated numbers representing copy numbers at 
each loci, were entered manually into the Birmingham TB register from laboratory 
reports and therefore subject to errors.  
 
2.5 The research dataset 
Rationale for the creation of a research dataset from the electronic Birmingham TB 
register is discussed in Chapter 1. This section describes methods used in preparing 
the research dataset.  
 
All data from the January 1980 to December 2011, including personal identifiers, 
were extracted for the research dataset. Data after December 2011 were not included 
for pragmatic reasons i.e. to enable sufficient time for ethical approval of the 
research prior to the start of the research period for the thesis in October 2012.  
 
Data were manipulated using Microsoft Access 2010 and R version 2.14.2 (R Core 
Team, 2017). 
 
 
2.5.1 Deduplication of the clinical database 
Individuals entered more than once in each of the case and contact tables could not 
be recognised as such in the clinical database. Therefore deduplication across both 
the case and contact tables was performed. A deterministic match using first name, 
last name, date of birth and one of either hospital number, NHS registration number, 
address or telephone number was employed to identify individuals within the data. 
The following minor mismatches were tolerated: up to 2 character differences in 
names; single difference in either day or month in date of birth (except in cases 
where the date of birth was entered as 1st January or was blank, an individual was 
matched if the year of birth, calculated from age, matched); difference in house 
number of address; or if the fourth required field was blank or unknown. For 
individuals with agreement on first name, last name and date of birth but who had no 
available hospital or NHS registration number and were discrepant on address or 
telephone number, a match was also made if further confirmation by either case note 
review or discussion with the clinical team was obtained. This procedure was 
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designed to ensure that matches were accurate at the expense of potentially missing 
matches, although no formal estimates of specificity and sensitivity are possible.  
 
2.5.2 Pseudonymisation 
The final tables contained 14,909 case episodes and 56,615 contact episodes. Unique 
individuals (N=63,620) were given new numerical identifiers. All personal 
identifiers were removed. All dates apart from notification and contact dates were 
reduced to years. The last two letters of postcodes were removed. 
2.6 Ethical approval 
Ethical approval to pseudonymise and analyse the Birmingham TB register was 
granted by the National Research Ethics Service, NHS Health Research Authority 
(reference number 13/EM/0126). 
2.7 Summary 
The large clinical dataset of TB cases and contacts in Birmingham, UK is a register 
of all individuals treated for TB (disease and latent infection) or named as a TB 
contact since 1980 in a defined geographical region. Data was censored at end 2011 
to create a pseudonymised research dataset used in this thesis. A conservative 
approach to identify repeat individuals was taken to ensure accuracy at the expense 
of missing some individuals.  
 
We can be reasonably certain of the register’s completeness with regards to the 
number of active TB cases but there are several sources of detection bias in 
ascertainment of latent TB infection cases and TB contacts. Tests for latent TB 
infection was only offered to select age groups and those diagnosed but not treated 
were not always recorded. Naming of contacts via contact tracing was voluntary and 
the extent of contacts asked for depended on case infectiousness but also directed by 
subjective clinical assessment on a case-by-case basis. Changes in clinical protocols 
over time have likely further impacted on latent TB infection and TB contact 
recognition and the time points at which these changes occurred were not always 
clear. Furthermore demographic and clinical data entered had variable completeness 
and formal estimates of precision in data entry are available.
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3 Time-dependent risks of recurrent tuberculosis 
treatment episodes 
 
3.1 Introduction 
The standard treatment regimen for tuberculosis (TB) since drug trials began in 1946 
has remained unchanged until today. To achieve durable cure six months of four 
drugs (isoniazid, rifampicin, ethambutol and pyrazinamide) are given for two 
months, followed by two drugs for a further four months. Global expansion of 
treatment by directly observed therapy (DOT), necessary to avoid incomplete 
treatment (due to the prolonged course of therapy) and the risk of resistance, has 
been a key strategy in TB control that has led to a 50% decline in global incidence 
rates compared to 1990 and nearly halving of mortality rates in 2015 (World Health 
Organization, 2017). 
 
Retreatment cases attributable to both relapse and reinfection may signal gaps in 
control programmes and therefore deserve investigation. Under trial conditions 3.4% 
relapse after five years in established treatment regimens (Hong Kong Chest Service 
and British Medical Research Council, 1987) . Current understanding of retreatment 
relies largely on patient recall of previous episodes with 10-20% and 4-13% 
reporting at least one previous diagnosis/treatment in low and high-income countries 
respectively (Kim et al., 2013; Mak et al., 2008; World Health Organization, 2017) 
 
In low-incidence countries (defined as <20 cases per 100,000) such as the UK, active 
case finding in at risk groups including contacts of TB cases and new migrants is an 
established additional control measure (National Institute for Health and Clinical 
Excellence, 2016). Testing and treatment of latent TB infection has been a routine 
component of this measure since the late 1960s for children (American Thoracic 
Society, 2000; Joint Tuberculosis Committee of the British Thoracic and 
Tuberculosis Association, 1973) and in the UK was extended to young adults under 
the age of 35 since 1990 (Subcommittee of the Joint Tuberculosis Committee of the
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British Thoracic Society, 1990). Progression to active disease is estimated to occur in 
around 4% despite treatment (Ena and Valls, 2005) and overall effectiveness is only 
60% with incomplete treatment adherence (Smieja et al., 2000). These estimates 
were pooled from studies with variable follow-up times. Systematic evaluation of 
long-term outcomes for treated latent cases including time since treatment is thus 
also valuable for programme evaluation. 
 
In this chapter we consider repeated episodes of latent and active TB diagnosis and 
treatment (referred to as a TB episode) to understand their contribution to TB 
epidemiology and its related risk factors in an urban UK setting. 
 
3.2 Objective 
By identifying repeat individuals in a longitudinal TB register spanning 31-years and 
applying a survival approach 
• Estimate short and long-term of risks of rediagnosis/retreatment after a first 
TB treatment episode (latent infection and active TB). 
• Analyse predictors of recurrent TB treatment episodes. 
• Infer the contribution of reinfection in recurrent TB treatment episodes by 
assessing available molecular typing data. 
 
3.3 Method 
3.3.1 Study design and setting 
We retrospectively analysed all TB treatment episodes diagnosed between the 
calendar years 1980 and 2011 in the city of Birmingham and urban borough of 
Solihull, UK: of 3223 latent and 11,387 active cases. Cases were extracted from the 
research dataset created from the Birmingham TB register as described in Chapter 2. 
All data were collected prospectively in the course of normal healthcare provision.  
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3.3.2 Study population 
The study population was all patients with a treatment episode for latent or active TB 
(both culture-confirmed and unconfirmed) residing in the study area. Patients that 
were subsequently found to have an alternative diagnosis and denotified were 
excluded. Patients with a previous TB treatment episode noted in the register (field 
16, Appendix 1.1) but who did not have that treatment episode treated in the study 
area were included; the treatment episode in the study area was considered as the 
first. No knowledge of treatment episodes outside the study area after a first TB 
treatment episode in the study area was possible.  
 
During the study period almost all active case finding effort were concentrated in 
contacts with only ad hoc cases found through screening in other at risk groups, 
hence the majority of latent cases were diagnosed as a result of contact to an index 
case. Latent cases are not statutorily reported but as all treatment were managed by 
specialist nurses based at the Birmingham Chest Clinic, the latent data are also likely 
to represent near comprehensive surveillance. Cases found to have latent infection 
but not given treatment were not registered and therefore could not be included in 
the study. However uptake of latent TB treatment was over 99% (Martin Dedicoat 
2017, personal communication, 2 October).  
 
3.3.3 Identification of individuals with repeat TB episodes 
Repeat individuals were searched for in the dataset using a minimum of four 
personal identifiers: first name, last name, date of birth and one of either hospital 
number, NHS registration number, address or telephone number was employed to 
identify individuals within the data. Further details of the deduplication process are 
described in Chapter 2 (section 2.5.1). 
 
 
3.3.4 Definitions 
A repeat TB episode was defined as any treatment episode for latent or active TB in 
the same individual that was registered at least 12 months after the first episode. 
Pulmonary TB was defined as TB affecting the lungs, pleural cavity, mediastinal 
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lymph nodes or larynx. Resistant TB was defined as an isolate with documented 
resistance to any first-line drug, i.e. rifampicin, isoniazid, pyrazinamide or 
ethambutol. Ethnicity was self-reported and Indian subcontinent ethnicity included 
those of Pakistani, Indian or Bangladeshi origin. Treatment outcomes at 12 months 
from diagnosis were defined as: treatment completed if patients completed a full 
course of prescribed treatment and had documented culture conversion or were 
discharged by their attending physician, treatment ongoing if a patient remained on 
treatment 12 months after diagnosis for any reason, defaulted for any patient lost to 
follow-up and died or transferred out if death from any cause occurred or if the 
patient moved out of the study area and care was formally transferred elsewhere. 
These definitions have not changed during the time course of the data collection. 
 
3.3.5 Laboratory methods 
All microbiological specimens were processed at Public Health England Regional 
Centre for Mycobacteriology, Birmingham. Drug susceptibility testing was 
performed using the resistance ratio or proportion method (Drobniewski et al., 
2007). Strain typing by 15 or 24-loci mycobacterial repetitive unit-variable number 
tandem repeats (MIRU-VNTR) (available from 2003 and 2011 for 15- and 24-loci 
respectively) was performed as described elsewhere (P Supply et al., 2001). 
 
3.3.6 Statistical analysis 
We estimated the rate of a second TB treatment episode by survival analysis. Time 
periods at risk for each person were defined in years as the time between date of first 
episode notification and date of second episode notification or censor date (date of 
death, transfer out of city or end of study period, 31 December 2011). A small 
number of individuals (17, 0.1%) had more than two TB episodes but these episodes 
were not further evaluated. Cumulative hazard functions for each pair of sequential 
episode types (active or latent infection followed by latent infection, active infection 
followed by active infection and latent infection followed by active infection) were 
plotted for time to the second TB episode only using the Nelson-Aalen estimator.  
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The following independent variables were fitted in a Cox proportional hazards model 
with stratification on TB episode number: age at first TB episode, sex, ethnic group 
and whether UK or non-UK born, type of first infection episode (latent; pulmonary 
or non-pulmonary culture-negative, culture-positive fully-sensitive or culture-
positive resistant TB), treatment outcome of first episode and year of first treatment 
episode diagnosis. The Efron approximation was used for tied events (i.e. where 
individuals had a second TB treatment episode at the same time and their individual 
contribution to the partial likelihood for covariates could not be evaluated). Multiple 
observations from the same individual were adjusted for using the robust variance 
estimator. Ethnicity and birthplace and type of infection episodes were grouped as 
described as exploratory analysis revealed the individual covariates to be highly 
collinear. Other variables such as history of previous TB, BCG status, risk factors for 
TB including alcohol or drug abuse, homelessness, history of incarceration and HIV 
status were available but data were missing for 25%-90% of individuals and 
therefore the influence of these variables was not assessed.  
 
The multivariable Cox model, stratified as above, was constructed by purposeful 
selection and proportionality of hazards was examined graphically from log-log 
hazard plots and from Schonfield residuals. Proportionality was violated for the 
notification year of first episode, and in an extended Cox model controlling for all 
other variables the relative hazard for notification in 2000-2011 (Period 2) was twice 
that of notification in 1980-1999 (Period 1). Period of first notification did not alter 
the hazard coefficients for other covariates in the model and its effect was therefore 
likely due to poorer repeat episode ascertainment in the earlier half of the study 
period when quality of data recording was poorer. Separate models were therefore 
constructed for Period 1 and Period 2. 
 
All analyses were performed using R version 3.1.2 (R Core Team, 2017) and the R 
survival package (Therneau, 2015). 
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3.4 Results 
3.4.1 Overall description of repeat TB treatment episodes 
From 14,798 registered latent and active TB episodes, 14,610 (99%) were included 
in the final analysis: 162 were excluded due to denotification, 14 due to unknown 
treatment episode type, 12 due to repeated treatment episode occurring within 12 
months (Figure 10). A total of 14,312 unique individuals were identified, of whom 
318 individuals (2%) reported a preceding TB treatment episode outside the study 
area. Overall a repeat TB episode occurred in 280 individuals (2%) (Table 1).  
 
Figure 11A shows the cumulative hazard for any repeat TB treatment episode. The 
risk of any repeat TB treatment episode was highest in the first five years after the 
initial episode and then declined with time. This risk varied by calendar year of 
initial treatment episode (Figure 11B). Those initially notified in the last decade of 
the register (2000-2011, Period 1) had a higher risk of a second treatment episode 
compared to those notified in the earlier part of the register (1980-1999, Period 2) (5-
year transition probability 1.7% (95% confidence interval, CI 1.4%, 2.2%) versus 
0.7% (95% CI 0.6%, 0.9%); 10-year transition probability 3.1% (95% CI 2.5%, 
3.8%) versus 1.4% (95% CI 1.2%, 1.7%). The risk for any repeat episode in an 
individual whose first episode was notified in Period 2, adjusted for age, sex, 
ethnicity and birthplace, type of first TB episode and treatment outcome, was twice 
that of an individual notified in Period 1 (adjusted HR 2.07, 95% CI 1.55, 2.77, 
p<0.001). Further analysis of repeat treatment episodes was therefore split by the 
notification period of the first episode. 
  
Chapter 3: Time-dependent risks of recurrent tuberculosis treatment episodes  
 
 43 
!Figure!10.!Active!and!latent!TB!treatment!episodes!notified!in!Birmingham!and!Solihull,!UK,!1980A2011!and!final!study!population!included!in!analysis.!N!=!number!of!individuals.!!
 !
No. of TB treatment episodes No. of individuals 
(N=14,312) 
1 14,032 
2 263 
3 16 
4 1 !Table!1.!Number!of!individuals!and!their!TB!treatment!episodes!from!14,610!notified!active!and!latent!cases!in!Birmingham!and!Solihull,!UK,!1980A2011.!!
Latent#infec&on#
N#=#3,188#(22%)#
Ac&ve#disease#
N#=#11,124#(78%)#
Culture8confirmed#
N#=#5,177#(47%)#
Culture8unconfirmed#
N#=#5,947#(53%)#
Repeat#episode#
N#=#83#(3%)#
Latent#infec&on#
N#=#14#(17%)#
Ac&ve#disease#
N#=#69#(83%)#
Repeat#episode#
N#=#93#(2%)#
Latent#infec&on#
N#=#10#(11%)#
Ac&ve#disease#
N#=#83#(89%)#
Repeat#episode#
N#=#104#(2%)#
Latent#infec&on#
N#=#10#(10%)#
Ac&ve#disease#
N#=#94#(90%)#
Culture8confirmed#
N#=#30#(32%)#
Culture8confirmed#
N#=#47#(57%)#
Culture8confirmed#
N#=#45#(65%)#
14,798#no&fied#ac&ve#and#latent#
TB#episodes#(198082011)#
N#=#14,479#
Deno&fied#episodes,#N#=#162#
#
Episode#type#unknown,#N#=#14#
#
Eepeat#treatment#episodes#within#12#
months#(<1%),#N#=#12#
14,610#treatment#episodes#
N#=#14,312#
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!
3.4.2 Demographic!and!clinical!characteristics!of!TB!cases!by!
calendar!time!
Significant changes in patient demography and the clinical characteristics of TB 
cases occurred over the prolonged study period (1980-2011) (Table!2). Compared 
to Period 1 (1980-1999) there was a large increase in the proportion of cases of 
Black African ethnicity from abroad (95% CI for difference in proportions 13.6%, 
15.5%) in Period 2 (2000-2011), while the proportion of cases in the White, UK-
born population decreased (95% CI for difference in proportions -8.2%, -5.9%). 
There was also marked increase in the burden of latent treatment cases (95% CI for 
difference in proportions 11.5%, 14.3%) and a reduction in the proportion of 
culture-negative cases (95% CI for difference in proportions for pulmonary cases -
17.5%, -14.7%) in Period 2 compared to Period 1. There was a small increase in the 
proportion of isolates with resistance to any first-line drug (95% CI for difference in 
proportion 1.2%, 2%).  The proportion completing treatment within 12 months was 
also lower in Period 2 (95% CI for difference in proportions   -6.8%, -5.1%) with a 
small increase in patients defaulting treatment (95% CI for difference in proportions 
2.1%, 3.1%). The proportion of missing demographic data (age, sex, ethnicity and 
birthplace) reduced in Period 2 compared to Period 1. 
          
              Figure!11.!Cumulative!hazard!for!any!repeat!TB!treatment!episode!(A)!and!cumulative!hazard!by!year!of!initial!treatment!episode!(B).!Period!1,!first!treatment!episode!notified!in!years!1980A1999;!Period!2,!first!treatment!episode!notified!in!years!2000A2011.!Dotted!lines!denote!95%!confidence!intervals.!
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3.4.3 Risks and predictors for active TB after latent infection treatment 
Sixty-nine of 3,188 individuals (2.2%) treated for latent infection developed active 
TB (Table 1). The median time between treatment episodes was 5.7 years 
(interquartile range, IQR 3.3, 7.1 years). Figure 12A shows the cumulative hazard 
plot for active disease after treatment for latent infection. This risk of developing 
active disease accumulated at a constant rate for up to 10 years following latent 
infection treatment (5 and 10-year transition probability in Period 1 1.2% (95% CI 
0.7%, 1.9%) and 2.6% (95% CI 1.9%, 3.6%) respectively). The risk for those who 
were treated for latent infection in Period 2 was no different (5 and 10-year transition 
probability in Period 2 1.6% (95% CI 0.9%, 2.5%) and 2.3% (95% CI 1.4%, 3.7%) 
respectively). 
 
The demographic profile of patients treated for latent TB infection is shown in Table 
3. Age, being of Black African (born outside the UK) ethnicity and year of first 
latent infection treatment episode were significant predictors on univariable analysis. 
In the multivariable Cox model only the year of first episode predicted development 
of active TB after latent infection treatment (adjusted hazard ratio, HR 1.05 (95% CI 
1.02, 1.09). 
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3.4.4 Risks and predictors of recurrent active TB 
A total of 177 of 11,124 individuals (1.6%) treated for active TB developed a further 
episode of active TB (Table 1). The median time to this event was 5.5 years (IQR 
3.3, 7.3 years). The cumulative hazard for recurrent active TB for individuals with a 
first treatment episode in Period 2 was similar to the risk of developing active TB 
following latent infection treatment (Figure 12B) (5 and 10-year transition 
probability 1.4% (95% CI 1%, 1.9%) and 2.7% (95% CI 2%, 3.5%) respectively). 
However individuals with a first treatment episode in Period 1 had a much lower risk 
of recurrent active TB (5 and 10-year transition probability 0.6% (95% CI 0.4%, 
0.8%) and 1.1% (95% CI 0.8%, 1.4%) respectively). 
 
Table 4 shows the demographic and clinical characteristics of patients with a single 
active TB treatment episode versus recurrent active TB treatment. On univariable 
analysis, patients with recurrent active TB were more likely to be older, of Indian 
subcontinent ethnicity (both UK and non-UK born) or other ethnicity (non-UK 
born), have a drug-resistant isolate (pulmonary or non-pulmonary disease) and either 
defaulted or still on treatment at 12 months from diagnosis compared to patients a 
single treatment episode. Recurrent active TB was also more likely if the first 
treatment episode was later in the study period. The final multivariable Cox model 
included all the above variables except being of other ethnicity (non-UK born) and 
treatment default at 12 months. There were no significant interaction effects between 
the variables. Being on treatment at 12 months after diagnosis of a first episode had 
the highest risk for recurrent active TB (adjusted hazard ratio 5.27, 95% CI 2.48, 
11.2). Compared to the White, UK-born population ethnic groups from the Indian 
subcontinent had an adjusted hazard ratio of 2.67 (95% CI 1.38, 5.15) and 1.79 (95% 
CI 1.07, 2.99) if UK-born and non-UK born respectively. The adjusted hazard ratios 
for age at first episode and year of first diagnosis were lower (1.06 (95% CI 1.03, 
1.09) and 1.04 (95% CI 1.01, 1.06) respectively).  
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3.4.4.1 Strain typing in recurrent active TB 
Of 177 patients with repeat treatment for active TB, 47 (27%) had culture-
confirmation in both episodes. Paired MIRU-VNTR strain typing was available in 
17/47 (36%) of patients. Typing was identical for 15/17 (88%) with an average of 4 
years (range 2-7 years) between relapse. Two pairs were identical at 24-loci, the rest 
were identical at 15-loci. Five of these cases clustered in three strain-type clusters in 
which the majority of individuals had social risk factors (alcohol, drugs and 
imprisonment). A further five clustered in a single 15-loci strain-type cluster 
associated with migrants from the Indian subcontinent and the remaining five were 
unique strain-type clusters. Of the two reinfection cases (different strain types in 
repeat episodes at 15-loci), one cultured 2 of the 3 strain-types associated with 
alcohol, drugs and imprisonment and the other had two different unique strain-types. 
The time to second episode was seven and four years respectively. 
 
3.4.5 Risks of latent infection treatment after active TB or latent 
infection treatment 
Only a small number of individuals (34/14,312, 0.2%) were treated for latent 
infection after an initial treatment episode for either latent infection or active TB 
(Table 1). The median time to this event was 7.7 years (IQR 4, 11.7 years). The 
cumulative hazard for this event was different for individuals with first treatment 
episode in Period 1 and Period 2 (Figure 12C). After any treatment episode in Period 
1, the 5- and 10-year transition probability to latent infection treatment was 0.03% 
(95% CI <0.01%, 0.1%) and 0.1% (95% CI 0.06%, 0.2%) respectively. For those 
with a first treatment episode in Period 2, transition probabilities at five and 10 years 
were higher at 0.4% (95% CI 0.2%, 0.7%) and 0.7% (95% CI 0.4%, 1.2%). 
 
In the univariable Cox model the only predictor of this transition was year of the first 
treatment episode (unadjusted hazard ratio 1.09 (95% CI 1.05, 1.13)). 
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!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !Figure!12.!Cumulative!hazard!of!repeat!TB!treatment!episodes!by!episode!types.!Dotted!lines!denote!95%!confidence!intervals.!Period!1,!first!treatment!episode!notified!in!years!1980F1999;!Period!2,!first!treatment!episode!notified!in!years!2000F2011.!
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3.5 Discussion 
This work adds to a contemporary understanding of retreatment TB in a setting 
where the disease is variably distributed in the population, particularly in migrants 
and those with social risk factors. 
 
Incomplete ascertainment of repeat individuals was a major limitation of our study. 
This would explain the higher risk of recurrent active TB episodes in Period 2 
compared to Period 1. Our findings are therefore the absolute minimum estimates of 
risk with true estimates likely to be closer to findings from Period 2, i.e. twice as 
high as Period 1. The analysis also misses individuals rediagnosed/retreated outside 
the study area. Similar observational/surveillance data recording elsewhere, in 
particular of latent TB diagnosis or treatment currently not included in national 
surveillance would be highly beneficial in refining these estimates. Data were poor 
for previous TB and vaccination status, indicating that patient recall is unreliable for 
estimation of repeat episodes. 
 
The estimated rate of recurrent active TB in our area is low, consistent with findings 
from other high-income country settings (Bang et al., 2010; Driver et al., 2001; 
Pascopella et al., 2011). Previous estimates were limited to culture-positive TB only 
and may have underestimated risk in a real clinical setting. The limited molecular 
fingerprinting data presented suggests that relapse (i.e. treatment failure) is more 
common than reinfection in our setting unless reinfection is from a common source. 
With strain typing routinely available, further increase in the culture rate for TB 
diagnosis is needed to confirm this finding. However data from low-incidence 
settings as well as some higher-incidence settings are similar (Bang et al., 2010; 
Bryant et al., 2013). 
 
There was no differential risk for active TB after latent infection in Period 1 and 
Period 2, perhaps due to increased ascertainment in Period 1 for children who 
comprised the bulk of latent infection cases at the time (in practice treatment was 
extended to those up to age 35 only in 2007 in Birmingham). Thus the burden of 
retreatment TB in similar settings is likely to come from both latent and active cases. 
Upscale of latent TB diagnosis and treatment is an increasing priority (Pareek et al., 
Chapter 3: Time-dependent risks of recurrent tuberculosis treatment episodes 
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2011) and our estimates of rates of progression to active disease, with the highest 
risk persisting up to 10 years after treatment, should inform clinicians and patients so 
that any subsequent active disease can be diagnosed at the earliest opportunity. DOT 
is only utilised for those with risk factors for non-adherence in the UK (National 
Institute for Health and Clinical Excellence, 2016) so adherence in latent treatment 
may be less complete than if DOT was routine. Using clinical data to distinguish 
recent from remote infection may enable prioritisation of those at higher risk of 
progression to active disease that would benefit from augmented treatment with 
weekly DOT using the simplified 12-dose rifapentine and isoniazid regime (Sterling 
et al., 2011). Progression to active disease after latent treatment may also be host-
dependent as differential patterns of host gene expression (modulating the immune 
response to infection) have been observed in patients with recurrent active TB 
compared to those with only a single episode of disease or latent infection (Mistry et 
al., 2007; Tufariello et al., 2003). Current diagnostic tools do not allow distinction 
between active disease and latent infection and disease may be subclinical. 
Computed tomography imaging has been proposed as an adjunct to better detect 
subclinical disease (Fujikawa et al., 2014) but will have cost implications that need 
further evaluation. 
 
The risk of repeat treatment for latent infection after latent or active TB was much 
lower. Data from Period 1 suggests that there is minimal incremental risk over time. 
Estimates from Period 2 are higher but longer follow-up time is required to draw 
conclusions about continuing risk beyond 10 years after the first episode. 
 
Continuing treatment beyond 12 months from diagnosis had 4-5 times the hazard 
ratio for a future active TB episode compared to treatment completion. There may be 
a need for clinical vigilance in such cases (Kim et al., 2013) with targeted 
interventions to ensure both treatment completion and selected extended follow-up, 
particularly as some of these patients will be those with a drug resistant isolate. 
Being of Indian subcontinent ethnicity independently increased the risk of recurrent 
active TB. The reason for this is unclear and no data in the literature suggests a 
biological basis for this. Thus one explanation for a differential risk based on 
ethnicity could be different re-exposure risks.  
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Age at first active TB treatment episode was also significant predictor in the 
multivariable Cox model for recurrent active TB. Risk of infection as well as disease 
following infection is strongly age-related (Rieder et al., 1990; Stead and Lofgren, 
1983). However a modelling study based on UK notification data from 1953 to 1988 
found that in adolescents and adults the risk of developing disease following 
reinfection was lower than the risk of developing disease after the first infection, 
suggesting that previous infection provides some protection (Vynnycky and Fine, 
1997). Based on the limited molecular data available recurrent active TB in our 
setting appears to be mostly related to relapse rather than re-infection and therefore 
the protective effect of previous infection may not apply.   
 
Successful strategies for TB elimination will rely on an integrated approach of 
vaccination and diagnosis and treatment for both active disease and latent infection 
(Dye et al., 2013). The relative contribution of each strategy to achieve this goal is 
likely to vary with the changing epidemiology of the epidemic in different settings 
and setting-specific modeling is crucial to refine efforts in control. Quantifying risks 
for repeated TB episodes may further contribute to model development. Such 
analyses require good epidemiological data gathering over extended periods. We 
have demonstrated the need to recognise repeat individuals over time to better 
understand the natural history of TB in our setting. Retreatment TB cases will arise 
from latent as well as active cases but existing national surveillance does not include 
data on latent infection diagnosis/treatment. We suggest that both the recording of 
patient identity and latent TB cases are important.
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4 What happens to tuberculosis contacts? Competing risks 
application to estimate risks of infection with single 
versus repeat exposures. 
 
4.1 Introduction 
In the United Kingdom (UK) tuberculosis (TB) diagnosis and treatment is readily 
accessible through comprehensive primary and secondary care health services. 
Besides early diagnosis and treatment, the mainstay of TB control is active case 
finding in at-risk groups, namely contacts of TB patients and new entrants to the UK 
(National Institute for Health and Clinical Excellence, 2016). 
 
Contact tracing is a key strategy of infectious diseases control. By identifying, 
isolating and/or treating individuals exposed to an infectious disease, further chains 
of infection are interrupted and disease spread curtailed. Contact tracing was first 
used successfully in sexually transmitted diseases (Wigfield, 1972) and is a 
recommended policy for controlling new or re-emerging infections such as severe 
acute respiratory syndrome (Donnelly et al., 2003) and Ebola (Rivers et al., 2014; 
World Health Organization, 2014). 
 
Contact tracing in tuberculosis emerged with the availability of effective drug 
regimens for both latent infection and disease in the 1950s (Ferebee and Mount, 
1962; Hsu, 1963). The prevailing approach follows the “-in-the-pond” principle 
(Veen, 1992) originally described by Van Geuns (Van Geuns et al., 1950)  who 
noted that more infected individuals were found with increasing intimacy of contact 
to the investigated case. In settings where the number of infectious cases is low and 
thus the overall risk of infection in the community is also low, the observed 
prevalence of infection or disease detected in individuals forming the most intimate 
contact ring of a case can be compared to that expected in the general population for 
the same age. Less intimate rings of contacts should be investigated until the 
observed prevalence in contacts is similar to the expected prevalence. This staged, 
directed process aims to identify all possible concurrent sources of infection in a 
Chapter 4: What happens to tuberculosis contacts? Competing risks application to 
estimate risks of infection with single versus repeat exposures. 
 
 56 
microepidemic, with new waves of concentric circles of contact tracing initiated 
from each case found. In Veen’s original description, contacts diagnosed with latent 
infection should not have their source of infection assigned to the known index case 
until their own contacts are assessed. 
 
Multiple factors determine disease transmission to contacts of infectious TB cases, 
i.e. pulmonary or laryngeal cases that generate airborne droplet nuclei containing TB 
bacilli. Concentration of droplet nuclei is affected by airflow which depends on 
ventilation and air circulation where contact occurs (Houk et al., 1968). The amount 
of exposure, i.e. frequency and duration of contact is also important. In practice, 
contacts are usually considered at risk if the cumulative exposure time is 8 or more 
hours; this duration was derived from observations of higher risk of transmission for 
airline passengers in the same or adjoining row (Driver et al., 1994; Kenyon et al., 
1996).  The relative contributions of proximity to the infectious case and length of 
exposure whether brief but recurrent or prolonged to transmission is not well 
understood, nor is it well quantified in practice. 
 
Certain characteristics of the infectious case affect the likelihood of transmission. 
The burden of infection, as measured independently by sputum-smear positivity, 
radiographic observation of lung cavities and shorter time to growth of M. 
tuberculosis (<9 days) in culture, correlates well with transmission (Bailey et al., 
2002; Marks et al., 2000; O’Shea et al., 2014). Once infected, the risk of progression 
to disease is age dependent being highest for children under 5 years and post-
pubertal adolescents (Comstock et al., 1974) and in those with impaired immunity 
for example due to HIV infection (Antonucci et al., 1995), systemic diseases such as 
diabetes (Dillon et al., 1952) or use of immunosuppressants such as anti-tumour 
necrosis factor agents (Gardam et al., 2003). 
 
The number of cases detected by contact tracing is higher in settings where there is a 
greater overall burden of disease with approximately 50% of contacts found to have 
infection in low and middle-income countries vs. 30% in high-income countries (Fox 
et al., 2013). Contact tracing may find cases both related and unrelated to the known 
source case. For example, contacts of non-infectious cases are also found to have 
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infection (Mandal et al., 2012; Underwood et al., 2003). Transmission in these cases 
could have been from remote exposure or recent exposure to an unknown infectious 
case. Inferring transmission from the known source case requires matching TB 
isolates by typing in both case and contact or documenting conversion of a 
previously negative TB-specific cellular immune response to positive. Up to 40% of 
treated TB cases are culture-negative (Public Health England, 2017b) and therefore 
unavailable for molecular typing. Furthermore an estimated 75-95% of contacts will 
already be infected by the time of tracing but few (1-3%) have had the time to 
manifest disease (Kasaie et al., 2014). Latent infection can be tested for but requires 
recent seroconversion to deduce likely transmission and this is seldom confirmed. 
Measuring linked transmission in contacts is therefore problematic. However 
because contact tracing accesses those at risk regardless of whether transmission 
occurred directly from known sources, studying contact characteristics and their 
long-term interactions, for example recurrent exposures may provide insight into 
network structure and ways to improve case detection (Read et al., 2008; Smieszek 
et al., 2009). 
 
The overall yield of case finding through contact tracing is easier to measure. 
However reported evaluations may be underestimated due to incomplete follow-up 
of contacts (up to 40%) (Cavany et al., 2017; Grinsdale et al., 2011; Saunders et al., 
2014) or limited follow-up time. Very few longitudinal studies of contact outcomes 
are published (Morán-Mendoza et al., 2007; Sloot et al., 2014) although a meta-
analysis has estimated a high annual incidence of disease at 5 years following 
exposure (171 per 100,000) (Fox et al., 2013). A further consideration when 
assessing yield in contact studies is that diagnosis of latent infection is only sought in 
younger individuals due to the excess risk of treatment-related hepatotoxicity with 
age (Stead et al., 1987). In the UK a test for latent infection was generally only 
considered for those aged 35 and under until 2016 (National Institute for Health and 
Clinical Excellence, 2016). Thus previous UK studies of contact tracing with shorter 
term follow-up (Rosser et al., 2018) may have underestimated  the rate of infection/ 
disease in older contacts.  
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TB registry data captures exposures, infection and disease events in a population 
over a long time course and may allow more comprehensive understanding of 
contact outcomes including impact of repeat exposures/contact episodes.  
 
4.2 Objectives 
Using an event history approach we aim to  
• Estimate the risks and timing of disease and infection in contacts with a 
single versus repeat contact episodes. 
• Investigate risk factors for outcomes after a single contact episode. 
 
4.3 Methods 
4.3.1 Study population 
Contacts named by all notified TB cases from 1987 to 2011 who were residing in 
Birmingham city and the urban borough of Solihull were included in this analysis. 
Cases were extracted from the Birmingham TB register as outlined in Chapter 2. 
Contacts were excluded if they were previously notified as a case. Contacts 
registered more than once within a period of 12 months and linked to the same index 
case were considered as duplicate registrations and only the first episode was 
included. TB cases were interviewed by TB nurses within five working days of their 
notification to elicit the names of persons they may have had regular contact with 
over the infectious period, defined as the date of onset of pulmonary symptoms, if 
known, or three months before diagnosis. For non-pulmonary cases only household 
contacts, defined as those who share a bedroom, kitchen, bathroom or sitting room 
with the case were elicited. For pulmonary cases with contacts identified at a 
congregate setting e.g. a workplace or school further contacts not directly named by 
the patient but known to have shared the enclosed space with the case were 
sometimes recruited if considered at risk after an on-site clinical assessment. 
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4.3.2 Contact investigation and management 
All contacts were invited to attend investigations at the local TB clinic. If numerous 
contacts required investigation in a congregate setting, investigations took place 
within the congregate setting.  
All contacts were screened for active TB by history taking, clinical examination, 
chest radiograph or other imaging as indicated and specimens for culture were 
collected where possible. For asymptomatic contacts aged 35 and under with normal 
chest radiography, latent infection was diagnosed by a positive Mantoux test as 
described elsewhere (National Institute for Health and Clinical Excellence, 2016; 
Public Health England and Department of Health, 2013) and/or positive interferon-γ 
release assay (QuantiFERON-TB Gold In-Tube, Carnegie, Cellestis, Australia or T-
SPOT.TB, Oxford Immunotec, Oxford, UK) performed at least 6 weeks after their 
last known exposure to the source case. Prior to 2007, only those aged 16 and under 
were investigated for latent infection. Contacts over 35 years but who had increased 
susceptibility to infection were tested for latent infection at clinician’s discretion.  
Contacts who failed to attend any part of their investigation were given two further 
appointments before referral back to their primary care provider advising that the 
individual had been exposed to TB and should be investigated for TB if symptoms 
develop. Disease or latent infection was managed according to national guidelines 
(National Institute for Health and Clinical Excellence, 2016). 
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4.3.3 Contact outcomes 
Contacts were searched for repeat entries in the contact dataset and case registry to 
determine if disease, latent infection or repeated exposure to TB cases/contact 
episode occurred. Repeat individuals were identified as described previously. The 
contact dataset did record outcomes at the end of the contact investigation protocol 
including no infection after examination, examination incomplete, latent infection or 
disease but data were unreliable. For example, 869 contacts documented as either 
having infection or disease were not subsequently notified as cases, whereas 296 
contacts documented as having no infection after examination or examination 
incomplete were registered as cases within a year of contact. Thus it was not possible 
to ascertain reliably which contacts had a negative test of infection during contact 
tracing. Additionally, contacts diagnosed with latent infection but not treated were 
not included as they were not registered as cases. Because the dataset only recorded 
those resident in the study area, cases that moved out were also not captured. 
4.3.4 Analysis of risks and predictors of disease, infection and repeat TB 
exposure 
 
Contact histories were described in a multi-state model (Figure 13). The initial state 
was the first contact exposure (C1). From this state contacts were at risk of a second 
contact exposure (C2), TB disease (D1) or latent infection (L1). Following a first 
occurrence of D1 or L1 no further transitions were modeled, i.e. they were absorbing 
states. Contacts transitioning to C2 were at further risk of a third contact exposure 
(C3), disease (D2) or latent infection (L2). D2 and L2 were different states from D1 
and L1. Further contact episodes after C3 were not modeled due to small numbers 
(n=23). Follow-up time was calculated from the notification date of the source case 
for the last contact episode. Follow-up was censored at the end of the study period 
(31 December 2011) or at the date of death or transfer out-of-city if recorded. 
Cumulative hazard rates for transition between states was enumerated using the 
Nelson-Aalen estimator and cumulative incidence functions for each end-point were 
compared using the Aalen-Johansen estimator. The Efron method was used for 
handling tied events. 
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The effect of the following covariates for each event were investigated in a cause-
specific hazards analysis: age at contact episode, sex, ethnicity, whether UK or non-
UK born, household or non-household exposure, index case disease (denotified or 
latent infection, pulmonary and non-pulmonary and whether culture positive or 
negative) and calendar year of contact episode. Ethnicity was self-reported and 
Indian subcontinent ethnicity included ethnic groups from India, Pakistan and 
Bangladesh. Age, household or non-household exposure and index case disease were 
a priori included in the multivariable Cox model. The final model was constructed 
by purposeful selection of other variables. Proportionality of hazards was examined 
graphically from log-log hazard plots and from Schonfield residuals.  
Analyses were performed in R version 3.1.2 (R Core Team, 2017) and the following 
packages: Biograph version 2.0.4 (Willekens, 2016) for data preparation and 
formatting; survival 2.37-7 (Therneau, 2015), etm version 0.6-2 (Allignol et al., 
2011) and mvna version 1.2-3 (Allignol et al., 2008) for hazards analyses and model 
selection and mstate version 0.2.7 (de Wreede et al., 2011) for prediction of time-to-
event for select contact characteristics.  
!Figure!13.!TB!contact,!disease!and!infection!model!to!investigate!the!importance!of!second!contact!episodes.!
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4.4 Results 
4.4.1 Overview of all contact episodes and outcomes 
From January 1987 to December 2011 there were 56,615 contact episodes involving 
52,776 individuals (contacts). Less than 2% of contact episodes were excluded either 
due to duplicate registration (n=53) or the contact had a documented previous 
infection from the disease register (n=961) (Figure 14).  Six per cent (2913/52,383) 
of contacts had more than one contact episode. The proportion of contacts found 
infected or diseased following a first, second and third contact episode was 6%, 8% 
and 13% respectively. 
!Figure!14.!Overview!of!TB!contact!episodes!and!outcomes!for!52,383!contacts!(individuals).!
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4.4.2 Study population 
There were 6530 index case notifications for the 52,383 contacts with up to two 
contacts episodes. The median number of contacts per index case was 5 (interquartile 
range, IQR, 3-9). Contacts were young with 18% aged 5 and under, 22% aged 6 to15 
and 35% aged 16 to 35 (Table 5). Fifty-one per cent were female. Country of birth 
and ethnicity were not recorded in 90% and 26% of contacts respectively. In the first 
contact episode, 56% were non-household contacts. Seventy-four per cent of 
contacts were contacts of pulmonary TB index cases, but only 48% of these index 
cases were culture-confirmed. 
 
4.4.3 Risk of infection and disease with single versus two contact 
episodes 
 
Table 6 shows the numbers at risk after a first (C1) or second (C2) contact episode 
and numbers transitioning to either disease (D1/D2), infection (L1/L2) or further 
contact episodes (C2/C3) over time. From C1, risk of C2 was lower than D1 or L1 in 
the first five years after contact but persisted up to 20 years such that the cumulative 
risk for C2 was highest overall (Figure 3 and Figure 4). Transition probabilities for 
these events with time are shown in Table 3. The risk of disease and infection from 
C2 was at least twice that from C1 (Figure 15 and Figure 16). One year after the 
contact episode, the probability for disease and infection from C2 were 3.9% and 
10.7% (95% CI 2.9%, 5% and 9%, 12.6% respectively) versus 1.6% and 3.7% (95% 
CI 1.5%, 1.7% and 3.5%, 3.9%) from C1 (Table 7). Risk of disease continued for a 
longer time period after C2 compared to C1 (Figure 15). After 10 years, the 
probability of D2 was 7% (95% CI 5.7%, 8.5%) versus 2.3% (95% CI 2.1%, 2.4%) 
for D1 (Figure 16 and Table 7).  
 
 
C
ha
pt
er
 4
: W
ha
t h
ap
pe
ns
 to
 tu
be
rc
ul
os
is
 c
on
ta
ct
s?
 C
om
pe
tin
g 
ri
sk
s a
pp
lic
at
io
n 
to
 e
st
im
at
e 
ri
sk
s o
f i
nf
ec
tio
n 
w
ith
 si
ng
le
 v
er
su
s r
ep
ea
t 
ex
po
su
re
s. 
 
64
 
!
 
Tr
an
sit
ion
 ty
pe
s 
 
1s
t  c
on
ta
ct 
!
 n
o 
ev
en
t 
1s
t  c
on
ta
ct 
!
 d
ise
as
ed
  
1s
t  c
on
ta
ct 
!
 in
fe
cte
d 
 
1s
t  c
on
ta
ct 
!
 2
nd
 co
nt
ac
t 
Va
ria
ble
 
N 
%
 
N 
%
 
N 
%
 
N 
%
 
Ag
e 
(m
ed
ian
 ye
ar
s, 
IQ
R)
 
21
 
9-
37
 
18
 
9-
31
 
11
 
5-
20
 
18
 
7-
34
 
Se
x 
 
 
 
 
 
 
 
 
   
  M
ale
 
22
51
6 
88
.9
 
48
8 
1.
9 
93
5 
3.
7 
13
92
 
5.
5 
   
  F
em
ale
  
23
37
7 
88
.2
 
62
8 
2.
4 
99
7 
3.
8 
15
19
 
5.
7 
   
  U
nk
no
wn
  
52
9 
99
.6
 
0 
0.
0 
0 
0.
0 
2 
0.
4 
Co
un
try
 o
f b
irt
h 
 
 
 
 
 
 
 
 
   
  U
K 
 
95
 
4.
1 
68
8 
29
.7
 
13
33
 
57
.4
 
20
6 
8.
9 
   
  N
on
-U
K 
 
15
55
 
55
.9
 
42
7 
15
.3
 
59
7 
21
.5
 
20
4 
7.
3 
   
  U
nk
no
wn
 
44
77
2 
94
.7
 
1 
0.
0 
2 
0.
0 
25
03
 
5.
3 
Et
hn
ic 
gr
ou
p 
 
 
 
 
 
 
 
 
   
  W
hit
e 
50
58
 
88
.6
 
13
9 
2.
4 
31
1 
5.
4 
20
4 
3.
6 
   
  B
lac
k C
ar
ibb
ea
n 
14
79
 
79
.8
 
12
8 
6.
9 
14
1 
7.
6 
11
2 
6.
0 
   
  I
nd
ian
 su
bc
on
tin
en
t 
23
23
5 
84
.8
 
71
5 
2.
6 
11
40
 
4.
2 
23
04
 
8.
4 
   
  B
lac
k A
fri
ca
n 
19
54
 
83
.7
 
93
 
4.
0 
21
1 
9.
0 
76
 
3.
3 
   
  O
th
er
 
14
26
 
86
.1
 
39
 
2.
4 
12
7 
7.
7 
64
 
3.
9 
   
  U
nk
no
wn
 e
th
nic
ity
 
13
27
0 
98
.8
 
2 
0.
0 
2 
0.
0 
15
3 
1.
1 
Ho
us
eh
old
 co
nt
ac
t 
 
 
 
 
 
 
 
 
   
  Y
es
 
20
04
3 
86
.9
 
60
8 
2.
6 
89
0 
3.
9 
15
20
 
6.
6 
   
  N
o 
26
37
9 
90
.0
 
50
8 
1.
7 
10
42
 
3.
6 
13
93
 
4.
8 
In
de
x c
as
e 
dis
ea
se
 
 
 
 
 
 
 
 
 
   
  D
en
ot
ifie
d 
or
 la
te
nt
 in
fe
cti
on
 
22
55
 
93
.2
 
24
 
1.
0 
46
 
1.
9 
95
 
3.
9 
   
  P
ulm
on
ar
y, 
cu
ltu
re
 p
os
itiv
e 
21
78
7 
86
.1
 
79
6 
3.
2 
13
27
 
5.
2 
13
89
 
5.
5 
   
  P
ulm
on
ar
y, 
cu
ltu
re
 n
eg
at
ive
 
12
09
7 
91
.4
 
18
1 
1.
4 
33
8 
2.
6 
61
5 
4.
7 
   
  N
on
-p
ulm
on
ar
y, 
cu
ltu
re
 p
os
itiv
e 
33
28
 
90
.3
 
47
 
1.
3 
98
 
2.
7 
21
2 
5.
8 
   
  N
on
-p
ulm
on
ar
y, 
cu
ltu
re
 n
eg
at
ive
 
61
83
 
93
.1
 
60
 
0.
9 
99
 
1.
5 
30
0 
4.
5 
   
  U
nk
no
wn
 
77
2 
69
.8
 
8 
0.
7 
24
 
2.
2 
30
2 
27
.3
 
Ye
ar
 o
f c
on
ta
ct 
(m
ed
ian
, I
QR
) 
19
99
 
19
92
-2
00
6 
20
00
 
19
93
-2
00
6 
20
05
 
19
98
-2
00
9 
19
91
 
 1
99
5-
20
01
 
IQ
R,
 in
te
rq
ua
rti
le 
ra
ng
e 
 Table!5
.!Demo
graphic
!charac
teristic
s!for!52
,383!co
ntacts!
and!na
ture!of
!their!f
irst!TB
!contac
t!expos
ure.!
Chapter 4. What happens to tuberculosis contacts? Competing risks application to 
estimate risks of infection with single versus repeat exposures 
 
 65 
!
Years since last  
contact episode 
<1 1-2 3-5 6-10 11-15 16-24 
At risk from 1st contact 52,383 46,814 44,321 37,396 28,162 20,281 
     Disease 797 126 106 62 23 2 
     Infection 1872 43 11 3 3 0 
     2nd contact 161 358 1,100 852 306 136 
At risk from 2nd contact 2,913 2,494 2,273 1,744 1,121 590 
     Disease 48 18 16 11 2 0 
     Infection 133 2 4 0 0 0 
     3rd contact 16 37 122 78 23 5 !Table!6.!Numbers!at!risk!of!events!(disease,!infection!or!further!contact!episode)!and!event!occurrences!over!time!following!a!first!and!second!contact!episode.!!!!!!!
!!Figure!15.!NelsonAAalen!estimates!of!the!cumulative!hazard!for!diagnosis!of!TB!disease,!latent!TB!infection!and!further!contact!episode!after!a!first!or!second!contact!episode.!Dotted!lines!denote!logAtransformed!95%!confidence!intervals.!!!!!!
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!Figure!16.!AalenAJohansen!estimates!of!the!cumulative!incidence!function!for!all!event!types!following!a!1st!and!2nd!contact!episode.!
!
Years 
since last 
contact 
episode 
Disease 
After 1st contact episode After 2nd contact episodes 
Probability  95% CI Probability  95% CI 
1 0.016  0.015, 0.017 0.039 0.029, 0.05 
2 0.018  0.017, 0.02 0.054 0.042, 0.067 
5 0.021  0.02, 0.022 0.064 0.051, 0.078 
10 0.023  0.021, 0.024 0.07 0.057, 0.085 
15 0.023  0.022, 0.025 0.071 0.058, 0.086 
20 0.023  0.022, 0.025 0.071 0.058, 0.086 
25 0.023  0.022, 0.025 0.071 0.058, 0.086 
 Infection 
After 1st contact episode After 2nd contact episodes 
 Probability  95% CI Probability  95% CI 
1 0.037 0.035, 0.039 0.107 0.09, 0.126 
2 0.038 0.036, 0.04 0.108 0.092, 0.126 
5 0.038 0.037, 0.04 0.111 0.094, 0.129 
10 0.038 0.037, 0.04 0.111 0.094, 0.129 
15 0.038 0.037, 0.04 0.111 0.094, 0.129 
20 0.038 0.037, 0.04 0.111 0.094, 0.129 
25 0.038 0.037, 0.04 0.111 0.094, 0.129 
 Further contact episode 
After 1st contact episode After 2nd contact episodes 
Probability  95% CI Probability  95% CI 
1 0.003  0.002, 0.004 0.013  0.008, 0.021 
2 0.01  0.009, 0.01 0.043  0.033, 0.056 
5 0.033  0.031, 0.035 0.122  0.105, 0.139 
10 0.053  0.051, 0.055 0.164  0.146, 0.183 
15 0.062  0.06, 0.065 0.18  0.161, 0.2 
20 0.067  0.064, 0.07 0.189  0.168, 0.21 
25 0.07 0.067, 0.074 0.196  0.172, 0.22 !Table!7.!Transition!probabilities!(AalenAJohansen!estimates)!for!event!types!after!first!and!second!contact!episode.!
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4.4.4 Risk factors for disease, infection and second contact after the first 
contact episode 
 
Detailed information on the cause-specific hazard ratios (CSHR) of risk factors on 
univariable analysis are shown in Table 8. 
 
On multivariable analysis country of birth, ethnic group and index case disease type 
were highly collinear. As country of birth was unrecorded for less than 10% of 
contacts this variable was excluded from the multivariable analysis. For time-to-D1 
from C1 the final multivariable model included all variables (including an interaction 
between age and ethnicity) except year of contact (Table 9). CSHR was highest for 
exposure to culture-confirmed pulmonary index cases (CSHR=4.61); culture-
negative pulmonary index cases had a lower impact (CSHR=1.79). Disease risk with 
exposure to non-pulmonary index cases was no different compared with exposure to 
denotified or latently infected cases. Black Caribbean ethnicity had a CSHR of 2.7 
compared to Whites (Table 9); this effect reduced with increasing age (Figure 17). In 
contrast, the CSHR for Indian subcontinent ethnicity increased from 0.54 to 1.03 
with increasing age (Figure 17). The main effect of age had a small reducing effect 
(CHSR=0.97). Other significant risk factors for disease were household contact 
(CHSR=1.54) and female sex (CSHR=1.23). 
 
For time-to-L1 from C1 the final model was similar to time-to-disease but excluded 
sex. Year of contact was a significant variable (CSHR=1.06, 95% CI 1.06, 1.07) but 
the survival curves for different calendar year of contact had relative hazards that 
were not constant with time i.e. they were non-proportional. Therefore the model 
was stratified by year of contact. The impact of pulmonary index case and household 
contact was lower compared to time-to-D1 (CHSR=2.88 for culture-confirmed and 
1.42 for culture-unconfirmed cases, CSHR=1.14 for household contact). The main 
effect of age had a small reducing effect (CHSR=0.93). Indian subcontinent, Black 
African and other ethnicity had a slightly higher risk for infection compared to White 
ethnicity with increasing age (CHSR 1.03, 1.04 and 1.04 respectively) (Table 9 and 
Figure 18). 
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The final model for time-to-C2 from C1 included age, sex, ethnicity and index case 
disease type only (Table 9). Age had a reducing effect on the time-to-C2 
(CSHR=0.99) while female sex had a slightly increased effect (CHSR=1.1). Indian 
subcontinent, Black African and Black Caribbean ethnicity had a greater risk of 
time-to-C2 (CSHR 2.56, 2.21 and 1.83 respectively) while other or unknown 
ethnicity had a lower risk (CHSR 0.28 for both) compared to White ethnicity. 
Pulmonary (both culture-positive and negative) and non-pulmonary (culture-positive 
only) index cases also had a greater risk compared to denotified or latently infected 
index cases (CSHR 2.09, 1.42 and 1.57 for pulmonary culture-positive, pulmonary 
culture-negative and non-pulmonary culture-negative respectively). 
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!
!Figure!17.!Predicted!cumulative!incidence!function!(Aalen8Johansen!estimates)!for!disease!in!male,!household!contacts!of!culture8positive!pulmonary!TB!patients!by!ethnic!group!and!first!quartile,!median!and!third!quartile!age!of!diseased!contacts.!
 
 
!Figure!18.!Predicted!cumulative!incidence!function!(Aalen8Johansen!estimates)!for!!latent!infection!in!male,!household!contacts!of!culture8positive!pulmonary!TB!patients!!by!ethnic!group!and!first!quartile,!median!and!third!quartile!age!of!infected!contacts.!!
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4.5 Discussion 
This analysis has shown empirically that a recurrent contact is a more common event 
than disease or infection within 10 years of the first contact and that recurrent 
contacts are at very high risk of both disease and infection. Contact repetition, an 
easily recognised entity, is thus an important indicator for TB case detection. A 
biological explanation is possible i.e. increased cumulative exposure following 
repeated contact to TB cases. Another possible explanation is that repeated contacts 
are part of a risk group with high prevalence of infection acquired remotely. For 
example infectiousness of the first index case appears to be less important for time-
to-C2 compared to time-to-D1 or -L1. Indian subcontinent and Black African 
ethnicity also had increased risk for time-to-C2 at all ages in contrast to time-to-D1 
or-L1. This suggests that C2 contacts may not be involved in direct chains of 
transmission. Instead contact repetition may signal community networks with a 
higher prevalence of TB compared to the general population. 
 
The yield of contact tracing in finding TB disease at one year was similar to that 
estimated for high-income settings in a previous meta-analysis (~1.4%) (Fox et al., 
2013).  Utilising record linkage and a survival approach in this analysis has enabled 
a closer evaluation of time-to-event. Thirty per cent of diseased contacts present a 
year after the index case was diagnosed. It is likely that these cases were not actively 
found through contact tracing which typically takes six to nine months to complete. 
A Dutch study using the same approach for 10-year registry data had similar results 
for contacts of pulmonary TB cases with 0.8% (74/9332) diseased within 180 days 
after the index case diagnosis and a further 0.4% (36/9213) diagnosed after 180 days 
(Sloot et al., 2014). A proportion of the diseased contacts diagnosed late in our study 
could be due to their ineligibility for latent infection screening. However the median 
age for this ‘missed’ group was 26 years (IQR 18-41). Thus a considerable 
proportion of cases may still have been preventable with consistent follow-up. 
Fewer cases of infection in contacts were found in this analysis compared to pooled 
estimates of 30% for similar high-income countries (Fox et al., 2013). This 
difference is likely attributable to the heterogeneity in the way latent infection is 
diagnosed (Erkens et al., 2010). 
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Age-related risks of infection and progression to disease following infection are well 
documented (Rieder et al., 1990; Stead and Lofgren, 1983) and consistent with 
findings here. Female susceptibility to disease is also well described (Comstock et 
al., 1974; Rieder et al., 1990) although the underlying cause is not clear. Differential 
risk from ethnicity and its interaction with age is more difficult to explain. Black 
Caribbean ethnicity was an independent predictor of molecular clustering in a 
London study (Maguire et al., 2002) suggesting increased genetic susceptibility 
although the impact of infecting TB clade was not studied.  
 
UK guidelines previously advocated the tracing of contacts from non-pulmonary 
index cases but since 2016 this group does not require further intervention (National 
Institute for Health and Clinical Excellence, 2016). This analysis has shown that 
these contacts do not have a greater risk of infection or disease compared to 
denotified or latently infected cases. However in the UK setting the yield from 
contact tracing this non-infectious group is not zero (Underwood et al., 2003) and 
therefore without any other route of intervention opportunities may be lost. 
 
There are several limitations to this analysis. The rate of infection after contact is 
likely an underestimate due to systematic screening of contacts under a certain age 
only and those infected but not treated were not included. Incomplete ascertainment 
of repeated contacts and linkages across the contact and case registry may also 
underestimate the transition rates between states. Nevertheless a competing risk 
approach has conclusively shown the increased risk of disease and infection in those 
with recurrent contact episodes. These contacts should be a high priority group in 
contact tracing procedures and control programmes should develop the means to 
recognise recurrent contacts.
  74 
5 The contact tracing network: global structure, local 
properties and extent of tuberculosis transmission 
 
5.1 Introduction 
In chapter 4 we established the rates at which individual contacts were diagnosed as 
cases. While demographic and clinical factors of the index case and contacts 
themselves influenced these transitions, the main finding i.e. that contacts with 
repeated exposure to tuberculosis (TB) cases were at higher risk of disease/infection 
suggests that the pattern of interactions in a community at risk is important in 
understanding disease distribution. Much understanding about the consequences of 
contact patterns evolved from mathematical models investigating the spread of 
sexually transmitted diseases. In such studies identification of a core-group of 
individuals with high partner change rate who associate with each other (“like with 
like” mixing), for example, appear to be important in the timing and size of an 
epidemic (R. M. Anderson et al., 1990; Ghani et al., 1997). More recently, contact 
patterns have been empirically fitted to transmission of airborne diseases. Spread of 
childhood infections such as parvovirus B19 and varicella correlate well with age-
specific contact rates but also intimacy of contact (e.g. household, long-duration and 
frequent) (Melegaro et al., 2011). In an investigation of the 2009 H1N1 influenza 
pandemic that began in a primary school, students social grouping into classes and 
grades were more predictive of infection transmission rather than physical proximity 
to an infectious case (Cauchemez et al., 2011). 
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Thus understanding of mixing patterns can help target those at highest risk, over and 
above known traditional host factors (which may be related to both biological and 
social structure/contact rate patterns). Direct examination of contacts have been 
undertaken to better inform contact rates that underpin theoretical transmission 
models, the largest of which was a diary-based cross-sectional survey across eight 
European countries (Mossong et al., 2008). Participants were asked to record their 
contacts over the course of a single day and the nature of contact, e.g. home/work, 
long/short, physical/non-physicial.  TB contact investigations similarly ask index 
cases regarding contacts and the type of contact had with these individuals during 
his/her infectious period. Not all contacts are recorded because generally only 
contacts that shared air space over a significant time period are enquired about, but 
contact investigation data may be a useful proxy to delineate subgroups of higher 
risk individuals by virtue of their contact patterns and refine estimates of contact 
rates between such subgroups. Mixing patterns uniquely important to TB 
transmission may exist due the inherent differences between the natural history of 
TB and other air-borne pathogens, primarily the long and variable incubation period 
(time between infection and onset of disease/diagnosis). Observation of contacts 
within short time intervals may therefore be limiting. 
 
Interest in knowing contact structure in TB grew from technological advances in the 
1990s that enabled genotyping of isolates to ascertain relatedness. Epidemiologically 
unlinked cases were thought to be in the same transmission link based on molecular 
similarity of the copy number and location of insertion sequence (IS)6110 (a mobile 
genetic element) (Bifani et al., 1996; Genewein et al., 1993). While these earlier 
molecular epidemiological studies suggested severe limitations in information 
gained through conventional contact tracing, whole genome sequencing has 
subsequently discriminated closely-related strains as different thereby helping rule 
out recent transmission where no epidemiological link could be found (Jajou et al., 
2018; Roetzer et al., 2013; Walker et al., 2013). Where true transmission trees have 
been signaled by whole-genome sequencing and subsequently epidemiologically 
confirmed, there has been increasing appreciation that social structure, in particular  
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information about shared locations is important (Gardy et al., 2011). Increasingly 
formal investigation of social structures relevant to TB has exploited network theory 
to characterise and relate its role in transmission. In the first description of network 
analysis to inform TB transmission, (Klovdahl et al., 2001) found that individuals 
and places/locations (the nodes) that were more centrally placed in a network  (a set 
of nodes connected by links) played an important role in an outbreak of 37 cases 
linked by IS6110 fingerprinting. Similar post-hoc analyses have further confirmed 
the utility of network measures in prioritisation of contacts with higher risk of 
infection (Andre et al., 2007; Kawatsu et al., 2015). 
 
This chapter is a descriptive analysis of the contact data of TB cases in Birmingham 
in a network context. The first section provides a comprehensive overview of the 
network, as it has never been systematically examined. The second section explores 
the relationship between whole network metrics and final component size: do certain 
network structures result in larger components? Leading on from this the third 
section attempts to learn if local metrics for an index case (egocentric approach) 
impacts on the number of infected contacts in his/her immediate circle. Finally, the 
fourth section combines available molecular (mycobacterial repetitive unit-variable 
number tandem repeats or MIRU-VNTR typing) data and the contact tracing 
network to determine the extent to which they overlap. 
 
The work presented differs from previous TB network studies in two ways (i) 
consideration of networks at a population level rather than limited to “outbreaks” or 
presumed transmission events linked by molecular epidemiology; and (ii) prolonged 
observation period of contact links relevant to the slow natural history of TB. Similar 
to published network studies in TB and other infectious diseases, we consider the 
data within a static network i.e. where links between people are fixed once formed 
and do not change with time.  In reality links are likely to be more fluid with time, 
albeit with some more stable connections between family for example. However 
theory on temporal or dynamic networks is still developing and are not applied here. 
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5.2 Objectives 
• Quantitatively describe the contact tracing network using network metrics  
• Examine network metrics that impact on the final, static network size  
• Explore the feasibility of using egocentric metrics to identify cases with a 
higher number of infected contacts. 
• Assess the utility of molecular typing (MIRU-VNTR) when interpreting 
contact tracing networks 
 
5.3 Method 
The contact tracing network refers to the total TB dataset of cases and contacts in 
Birmingham and Solihull, 1980 – 2011. Creation of this dataset and collection of 
contact data is described fully in Chapter 2. We included denotified cases (N=162) 
and their contacts, these individuals were labelled as a contact only for this purpose. 
 
All data preparation and analyses were conducted in R version 3.3.3 (R Core Team, 
2017).  
 
5.3.1 Terminology 
Similar to previous chapters infected denotes an individual infected with either latent 
TB or active disease. Individuals were also identified as either an index case or 
contact. A contact is further characterised as either household, close or casual. Table 
10 summarises the definition for these terms, in alphabetical order. 
 
Standard network terminology was adapted from (Hanneman and Riddle, 2005) and 
explained in Table 11. Network metrics were calculated using the R package igraph 
(version 1.1.2) (Csardi and Nepusz, 2006). Table 12 provides an explanation for 
network-level and node-level metrics used in this chapter. Edges between nodes 
were distinguished as household, close or casual according to relationship between 
the nodes, but were not weighted.  
 
 
 
Chapter 5. The contact tracing network: Global structure, local properties and extent 
of tuberculosis transmission 
  
 
 78 
 
Term Definition 
Casual contact 
 
An individual not named directly by an index case but identified to be 
present at the same non-residential address at the time of the infectious 
period of the index case 
Close contact An individual named by an index case but does not reside at a mutual 
residential address  
Household 
contact 
An individual named by an index case and resides at a mutual residential 
address 
Index case An infected individual with at least one contact 
Infected Infected with either latent TB or (active) disease !Table!10.!Definition!of!terms!defining!individuals!in!the!contact!tracing!data.!
 
Term Explanation 
Clique An undirected component where every distinct pair of nodes are linked to 
each other 
Component A set of nodes that are all reachable from every other 
Degree Number of edges associated with a node 
Indegree is the number of edges the node receives 
Outdegree is the number of edges the node sends 
Directed edge Edges have a direction, from the case to the contact 
Edge The relationship or link between nodes. 
Two nodes are adjacent if an edge exists between them. 
Egocentric Analysis on an individual node, with each node treated as a separate 
unit/case 
Network The total collection of edges between nodes. Some nodes may not have 
edges to another node 
Node An individual 
Sociocentric Analysis on whole network, with each network being a separate unit/case 
Triplet A component of three nodes 
Undirected edge Nodes are not classified as a sender or receiver of an edge !Table!11.!Definition!of!network!terminology!adapted!from!Hanneman!and!Riddle!(2005).!!!!!!!
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Term Calculation 
Network/sociocentric level 
Assortativity 
coefficient 
The degree to which nodes associated with those similar to themselves, 
calculated according to (Newman, 2002). This coefficient ranges from -1 
to 1 with coefficients >0 denoting homophily and <0 denoting dissortative 
mixing 
Density Number of links expressed as a proportion of all possible links between 
nodes (N*(N-1)/2)  
Diameter The maximum shortest path length between any two nodes in a 
component, assuming an undirected and unweighted network. 
Clustering 
coefficient 
The number of closed triplets/the number of triplets, with edge direction 
and weights ignored. In addition components with no triplets of nodes 
were not included in the global average 
Reciprocity The number of (unordered) node pairs that had reciprocal edges divided 
by the number of (unordered) node pairs that had no edge between them 
plus the number of node pairs that had non-reciprocal edges (a directed 
network was assumed) 
Node/Egocentric level 
Adjacent Two nodes are adjacent if linked by an edge 
Betweenness 
centrality 
The sum of the number of paths that pass through it divided by the total 
number of shortest paths for each pair of nodes in the graph. This score 
was normalised by (N-1)(N-2)/2 (considering an undirected path) as the 
score scale with the number of pairs of nodes in the graph. Nodes with 
high betweenness centrality scores act as bridges between other nodes 
in the network. 
Closeness 
centrality 
The reciprocal of the average length of the shortest path between a node 
and all other nodes in the graph. Nodes with higher closeness centrality 
scores reach other nodes in the network quicker. 
Degree centrality The number of incident edges on a node, normalised by the maximum 
number of edges possible (N-1). Edge direction is ignored. 
Eigenvector 
centrality 
The weighted sum of the centrality of the nodes linked to the node in 
question. 
Shortest path 
length 
The number of edges, between a pair of nodes in a component, which 
traverses the minimal number of edges. !Table!12.!Definition!of!network!metrics!adapted!from!the!R!package!igraph!(version!1.1.2)!(Csardi!and!Nepusz,!2006).!!
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5.3.2 Network visualisation 
Network visualisation was performed using the R package igraph (version 1.1.2) 
(Csardi and Nepusz, 2006). An individual with multiple infection events was labeled 
according to their earliest infection status only. Contacts who later became cases 
were labeled according to their infection status alone. Contacts never infected (i.e. 
never diagnosed as a case) during the study period were labeled as a contact. 
 
5.3.3 Descriptive comparison of components in the contact tracing 
network 
Components were grouped as small, medium or large based on their diameter (1 – 2, 
3 – 4, 5 or more respectively). An outlying component with diameter 23 was 
excluded from further comparison due to its extreme size. This component will be 
discussed separately in Chapter 6.  
 
The total number of nodes, infected nodes and proportion infected in each 
component was calculated. The following network metrics were evaluated: 
component density, clustering coefficient and reciprocity. Triplets of two diseased 
nodes and one non-infected node (who will not have an outdegree) were excluded 
when clustering coefficient was considered. The two-proportions z test was used to 
compare proportion infected between components of different sizes. The Wilcoxon-
rank-sum or the Kruskal-Wallis test was used to compare network metrics because 
values were not normally distributed. 
 
5.3.4 Evaluation of degree distribution 
Because contact investigation differed for pulmonary (household and close contacts 
assessed), non-pulmonary (household contacts only assessed) and latent-infected (no 
contacts assessed) cases, degree distribution was enumerated by infection type in 
each node. Median outdegree between node disease types were compared using the 
Wilcoxon-rank-sum test.   
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5.3.5 Relating network metrics to number of infected contacts  
Egocentric networks for each pulmonary and non-pulmonary index node who named 
at least one contact were examined to evaluate whether their position in the network 
at the point of diagnosis (i.e. before they had named contacts) influenced the number 
of infected contacts they had. 
 
5.3.6 Comparison of the contact tracing network and molecular network 
To assess the utility of contact tracing and typing in inferring disease transmission, 
all typed, culture-positive cases from 2004 onwards were assessed for a match on 
15- or 24- mycobacterial repetitive unit-variable number tandem repeats (MIRU-
VNTR) loci. All genotyping was performed prospectively at the Public Health 
England Regional Centre for Mycobacteriology, Birmingham using methods 
described by (Supply et al., 2001). Strain typing using 24-loci was only performed 
from 2011 onwards. 
 
MIRU-VNTR profiles were considered identical if it matched on all loci or had up to 
two missing loci but matched on all other available loci. Cases with identical MIRU-
VNTR profiles were considered epidemiologically linked if they were in the same 
connected component. Singular typed cases in components with no other typed cases 
in the same component were excluded. Each (unordered) case pair was then 
considered individually to estimate the sensitivity and specificity of epidemiological 
linkage in predicting molecular linkage and vice versa. 
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5.4 Results 
5.4.1 Overview of the static contact tracing network 
During the study period there were 14,909 infection episodes in 14,590 individuals 
and 56,562 contact episodes in 53,344 individuals. Sixty-seven per cent 
(9703/14,590) of infected individuals were involved in contact tracing networks 
either as an index case naming contacts (42%), by being named as a contact (20%) 
or both (5%) (Figure 19). The vast majority of contacts (93%) were not diagnosed 
with infection. !
!Figure!19.!Status!of!64,334!individuals!in!the!case!and!contact!database.!Shaded!areas!denote!those!involved!in!contact!tracing!networks.!!
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5.4.2 Components in the static contact tracing network 
5.4.2.1 Distance 
Individuals in the contact tracing network formed a total of 5729 separate connected 
components. Ninety-one per cent (5192/5729) of components were of star topology: 
a central infected node with outgoing edges to one or more contact nodes. These star 
components were of diameter 1 or 2 (Figure 20A and Figure 20B). Component 
topology changed if infected contacts named more contacts (Figure 20C, left-hand 
subgraph) or if separate star components had mutual contacts (Figure 20C, right-
hand subgraph). Two per cent (118/5729) of components had a diameter of 5 or 
greater (Figure 20E). This included one largest component with diameter 23 
containing 5% (3148/59534) of all nodes in the contact tracing network. This 
outlying largest component was excluded from further analysis in this chapter and is 
discussed in Chapter 6. 
 
For diseased nodes in the same component the vast majority were adjacent i.e. 
connected by one path length (Figure 21). Iterative contact tracing (outgoing edges 
in the directed network) reached a maximum of five path lengths. However when 
both outgoing and incident edges were considered in an undirected network the 
maximum shortest path length between diseased nodes was 12. The path length of 2 
in the undirected network is the artifact mode path length because it also reflects the 
common scenario of two infected contacts with an incident edge from the same 
index node. 
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!!!
!!Figure!20.!Undirected!and!unweighted!diameters!of!5,729!connected!components!in!the!static!contact!tracing!network.!The!directed!and!weighted!(different!edge!types)!subgraphs!are!shown!to!illustrate!evolution!of!the!contact!tracing!network.!Node!labels!denote!the!year!of!diagnosis.!
Pulmonary case
Non−pulmonary case
Latent case
Contact only
Household
Non−household
Casual
Diameter 5 or more 
(n = 118) 
A B 
C 
D 
E 
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!Figure!21.!Pairwise!distance!distribution!between!9,247!infected!nodes!in!the!directed!and!undirected!contact!tracing!network.!Numbers!above!bars!denote!actual!number!of!pairs!with!the!path!length.!The!largest!component!was!excluded.!
 
 
 
5.4.2.2 Cohesion 
Table 13 summarises network characteristics of the contact tracing network by 
component size. Small components (i.e. components with diameter 1 to 2) had a 
median of 6 nodes (interquartile range, IQR 4 – 9). The median number of nodes in a 
component doubled with increasing diameter: 15 (IQR 11 – 25) in medium 
components (diameter 3 to 4) and 47 (IQR 31 – 72) in large components (diameter 5 
or greater).  The median number of infected nodes increased with increasing 
diameter (1, 3 and 7 for small, medium and large components respectively). Medium 
components had a marginally higher proportion of their nodes infected when 
compared to small and large components (median proportion infected 0.2 (IQR 0.03 
– 0.29) versus median of 0.2 (IQR 0.01 – 0.25) and 0.17 (IQR 0.01 – 0.28 
respectively, P<0.01).  
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Density reduced with increasing component size and differences were significant 
between components of all sizes (median density for small, medium and large were 
0.35 (IQR 0.22 – 0.5), 0.17 (IQR 0.09 – 0.22) and 0.06 (IQR 0.03 – 0.06) 
respectively, P<0.001). 
 
The overall clustering coefficient between diseased nodes in the contact tracing 
network was 0.01 (Table 13).  Five per cent (270/5728) of components had at least 
one triplet of diseased nodes. In 93% (70/75) of small components, 69% (83/121) of 
medium components and 65% (48/74) of large components the probability that a 
triplet closed to form a clique was zero. The clustering coefficient distribution was 
similar between medium (median 0, IQR 0 – 0.38) and large components (median 0, 
IQR 0 – 0.32) (P=0.74) but different between small (median 0, IQR 0 – 0) and 
medium/large components (P<0.001). 
 
When only diseased nodes were considered in the contact tracing network, the global 
reciprocity or probability of a mutual connection between two (diseased) nodes was 
0.06. Only 11% (653/5728) of components had at least two diseased nodes with 95% 
(282/296) of small, 83% (214/258) of medium and 80% (78/98) of large components 
having a reciprocity of zero. Similar to the clustering coefficient distribution there 
was a difference in reciprocity distribution between small and medium/large 
components (P<0.001) but no difference between the large and medium components 
(P=0.74). 
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 Component size Small Medium Large 
 Diameter 1 – 2 
(N=4517) 
3 – 4 
(N=419) 
≥ 5 
(N=117)  
No. of nodes Mean 8 20 60 
SD 6.27 12.89 45.98 
Minimum 3 4 10 
Maximum 144 131 285 
Percentiles     25 4 11 31 
                       50 6 15 47 
                       75 9 25 72 
No. of infected 
nodes 
Mean 1 4 10 
SD  0.81 2.4 7.36 
Minimum 1 2 3 
Maximum 12 16 43 
Percentiles     25 1 2 4 
                       50 1 3 7 
                       75 1 4 12 
Proportion  
infected 
Mean 0.21 0.23 0.2 
SD 0.13 0.13 0.12 
Minimum 0.007 0.032 0.014 
Maximum 1 1 0.7 
Percentiles     25 0.13 0.13 0.12 
                       50 0.2 0.2 0.17 
                       75 0.25 0.29 0.28 
Density Mean 0.35 0.17 0.06 
SD 0.17 0.1 0.04 
Minimum 0.01 0.02 0.0007 
Maximum 1.33 0.5 0.2 
Percentiles     25 0.22 0.09 0.03 
                       50 0.33 0.15 0.05 
                       75 0.5 0.22 0.08 
Clustering 
coefficient of 
diseased nodesa 
 N=75 N=121 N=74 
Mean 0.05 0.21 0.15 
SD 0.2 0.35 0.22 
Minimum 0 0 0 
Maximum 1 1 1 
Percentiles     25 0 0 0 
                       50 0 0 0 
                       75 0 0.38 0.32 
Reciprocity of 
diseased nodesb 
 N=296 N=258 N=98 
Mean 0.04 0.09 0.05 
SD 0.19 0.25 0.16 
Minimum 0 0 0 
Maximum 1 1 1 
Percentiles     25 0 0 0 
                       50 0 0 0 
                       75 0 0 0 
SD, standard deviation 
aComponents with no triplets of diseased nodes were excluded. 
bComponents with no edge between diseased nodes were excluded.   
 !Table!13.!Descriptive!statistics!for!5,728!connected!components!in!the!static!contact!tracing!network.!The!largest!component!with!diameter!23!was!excluded.!
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5.4.2.3 Degree distribution 
 
Table 14 shows the number contacts named by infected nodes (outdegree). The 
outdegree varied by type of infection in the index case and type of edge (household, 
close or casual contact). The median number of household contacts (household 
outdegree) for nodes withpulmonary disease was two (IQR 0 – 5) versus three (IQR 
1 – 5) for nodes with non-pulmonary disease (P<0.001).  
 
The median number of close contacts (close outdegree) for nodes with pulmonary 
disease was also low - one (IQR 0 – 5) (Table 14). Thirty-nine per cent (2,075/5,293) 
of nodes with pulmonary disease did not name any close contacts. Nodes with non-
pulmonary disease and latent infection did not routinely have contacts outside the 
household traced. Thus their close outdegree was lower compared to nodes with 
pulmonary disease. 
 
Casual contacts in congregate settings were sought in only 16% (858/5,293) of nodes 
with pulmonary disease. The majority (85%, 551/858) that did have casual contacts 
sought had a maximum casual outdegree of two. Nodes with non-pulmonary disease 
and latent infection were not considered infectious but casual contacts were 
documented for 10% (223/2140) and 2% (55/2290) of non-pulmonary and latent 
nodes respectively. 
 
 No. of household 
contacts 
No. of close contacts No. of casual contacts 
Type of disease P  NP  Lb P NP Lb P NP Lb 
Mean  3.25 3.18 0.56 3.82 1.53 0.23 0.45 0.14 0.03 
SD  4.56 2.9 1.69 7.15 3.25 1.27 4.61 0.49 0.19 
Minimum  0 0 0 0 0 0 0 0 0 
Maximum  138a 31 25 111 71 35 168 7 2 
Percentiles 25 0 1 0 0 0 0 0 0 0 
 50 2 3 0 1 0 0 0 0 0 
 75 5 5 0 5 2 0 0 0 0 
 P, pulmonary; NP, non-pulmonary; L, latent infection; SD, standard deviation 
aThis involved a large contact tracing exercise at a single hostel 
bContacts were not solicited but volunteered by these latent cases !Table!14.!Outdegree!distribution!for!nodes!with!pulmonary!disease!(n=5,293),!nonBpulmonary!disease!(N=2,140)!and!latent!infection!(N=2,290),!by!type!of!edge.!
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The distribution of indegrees (of all types) differed between node infection type 
(P<0.001 for each two-way comparison) (Figure 22). A higher proportion of nodes 
with pulmonary disease had at least one indegree when compared to nodes with non-
pulmonary disease (24%, 1263/5293 versus 13%, 274/2140) while the majority of 
nodes with latent infection (85%, 1955/2290) had at least one indegree.  
 
!Figure!22.!Indegree!distribution!(household,!close!and!casual)!for!nodes!in!the!contact!tracing!network,!by!node!infection!type.!
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5.4.2.4 Mixing patterns 
Table 15 shows the assortativity coefficients for nodes linked by different edge 
types. In household case-contact pairs mixing was highly assortative by ethnic group 
and postal sector as expected (0.94 and 0.96 respectively). Among non-household 
case-contacts the assortativity coefficient for ethnic group remained high (0.88) but 
it was much lower among casual case-contacts pairs (0.27).  !
Edge type  N Assortativity coefficient 
Age Sex Ethnic group Postal sector 
Household 29,653 0.03 -0.01 0.94 0.96 
Non-household 26,174 0.02 0.003 0.88 0.27 
Casual 2,890 0.09 0.05 0.27 0.1 
All 54,771 0.03 -0.02 0.89 0.6 !Table!15.!Mixing!patterns!between!pairs!of!nodes!linked!by!household,!close!(nonShousehold)!and!casual!edges.!!
 
 !!!!!!!!!!!!!!
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5.4.2.5 Network metrics and number of infected diagnosed 
Figure 23 shows the distribution of number of infected contacts by the number of 
contacts named (outdegree). Finding an infected contact was a rare event with the 
median number of infected being greater than one only for pulmonary cases with 
very high outdegrees - 15 or greater for household contacts (Figure 23A and Figure 
23B) and 25 or greater for non-household outdegrees (Figure 23C and Figure 23D). 
 
Centrality measures for index cases that had no infected or at least one infected 
contact were mostly similar (Figure 24). Of centrality scores only the eigenvector 
centrality differed between cases who had none or at least 1 infected contact 
diagnosed (mean eigenvector centrality 0.969, 95% CI 0.965 – 0.973 versus 0.945, 
95% CI 0.933 – 0.957, P<0.001) (Figure 24A). Mean betweenness centrality score 
was 0.010 (95% CI 0.003 – 0.017) versus 0.018 (95% CI 0.001 – 0.034) (P=0.2) 
(Figure 24B), median degree centrality score was 0.071 (IQR 0.027 – 0.167) versus 
0.067 (IQR 0.036 – 0.2) (P=0.2) (Figure 24C) and median closeness centrality score 
was 0.2 (IQR 0. 174 – 0.24) versus 0.2 (9% CI 0.178 – 0.244) (P=0.74) (Figure 
24D).  
 
When clustering coefficiency of the network once an index case had named his/her 
contacts were considered (but before any of the contacts were diagnosed if infected 
and named their secondary contacts) the mean score in index cases with at least one 
infected contact was 0.019 (95% CI 0.014 – 0.024) versus 0.01 (95% CI 0.008 – 
0.012) (P=0.002). 
 
Infected contacts were diagnosed both prior to and after infection diagnosis in the 
index case (Figure 25). More infected contacts of non-pulmonary index cases were 
diagnosed prior to infection diagnosis in the index case compared to contacts of 
pulmonary index cases. For infected contacts diagnosed after the index case 
diagnosis, the majority occurred within the following five years. 
 
Compared to infection diagnosed de novo (i.e. in an individual not known to be a 
contact in the past), infected contacts had a shorter duration of symptoms by 11 – 28 
days (P<0.05). 
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!Figure!23.!Box!plots!of!the!number!of!infected!contacts!for!pulmonary!(N=5,293)!and!nonSpulmonary!(N=2,140)!index!cases!(with!at!least!one!outdegree),!by!edge!type!and!number!of!outdegrees.!Median!number!is!denoted!by!band!in!the!centre!of!boxes,!first!and!third!quartile!by!box!edges,!maximum!number!within!1.5!times!the!interquartile!range!by!the!uppermost!whisker,!outliers!by!circles.!!
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!Figure!24.!Distribution!of!centrality!measures!for!nodes!with!no!infected!contacts!(solid!line)!versus!egos!with!at!least!one!infected!contact!(dotted!line).!!
 
 
  
!Figure!25.!Distribution!of!time!between!infection!diagnosis!in!an!index!case!and!contact!by!disease.!!
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5.4.3 MIRU-VNTR typing 
Mycobacterial interspersed repetitive unit-variable number tandem repeat (MIRU-
VNTR) typing was universally available from year 2004 onwards in the study area. 
Although over 80% of culture-positive cases were typed, just over half (55%) of all 
diseased cases were culture-positive and available for typing (Figure 26).  
 
 
!Figure!26.!No.!of!typed!isolates!compared!to!the!total!burden!of!disease!by!year.!
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Sixty four per cent (1184/1848) of typed cases were in components with at least two 
typed cases. These cases were considered in unordered pairs and occurrence in the 
same connected component (i.e. presence of an epidemiological link) and match on 
MIRU-VNTR typing (i.e. presence of a genotypic link) was assessed. The overall 
sensitivity of epidemiological linkage in predicting molecular linkage was only 2% 
(48/2814, 95% CI 1 – 2%) and specificity was 100% (Table 16). Conversely, the 
sensitivity of molecular linkage in predicting epidemiological linkage was 39% (95% 
CI 30 – 48) (Table 17). Sensitivities did not alter significantly by demographic or 
clinical characteristics of case pairs (Table 17). 
 
 
 
! ! Contact!tracing!network!
! ! Linked! Not!linked!
Typing!by!
MIRU:
VNTR!
Linked! 48! 2766!
Not!linked! 76! 697446!!Table!16.!Genotypic!and!epidemiological!links!for!1184!diseased!nodes!involved!in!contact!tracing!networks!evolving!from!2004!onwards.!Numbers!denote!counts!of!(unordered)!node!pairs.!
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5.5 Discussion 
In contrast to extensive examination of contact networks relevant to sexually 
transmitted diseases (Doherty, 2011) only a handful of studies have investigated TB 
contacts networks as outlined in the introduction. In TB network studies done in the 
context of transmission (known due to molecular epidemiology), the network 
approach provided information about the immediate, local contacts who were at 
higher risk of infection. A few studies investigated networks across their population 
irrespective of transmission (Cook et al., 2007; Cozatt, 2016). These studies were 
small with less than 200 cases and spanned short time frames (up to 3 years). Thus 
description of the very large network in Birmingham over a long time frame may add 
new data about how contact tracing networks can be used to ascertain not only 
causality (i.e. transmission) but identify interventions (i.e. the community at risk).  
 
The network that can be constructed from contact tracing data are subject to several 
complications. Because the data was collected over time both past and future 
individuals and/or their links are censored so only a partial view of the complete 
network is obtained. Individuals may have many interactions that come and go over 
their lifetime and this dynamic process it not taken into account as our network was a 
analysed from a static viewpoint. Thus not all links observed may be relevant at a 
particular time. The other difficulty is the incompleteness of contacts as identified 
through contact tracing. Collection of contact data was biased because contacts were 
sought differently for infectious and non-infectious TB cases. In addition the 
collection method was not standardised (unstructured interview) and contact 
identification was voluntary.  
 
Nevertheless the contact tracing network was fragmented with over 90% of 
components remaining small (up to ten individuals within 1-2 path lengths). Within 
clusters individuals were loosely connected with low density, clustering coefficiency 
and reciprocity. The low measures of cohesiveness are likely a consequence of the 
way contact tracing is done rather than a reflection of the true network, for example 
for clusters of individuals within a household only edges from an index case to his/ 
her household members are recorded. As contacts becoming a case was a rare event 
(just under 90% of all component contained just one case), edges between non-
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infected household members are falsely absent. As the number of cases increased 
components grew in diameter and clustering coefficiency and reciprocity also 
increased.  
 
Larger components were rare and their significance are unclear. Is it possible to limit 
their growth? The distribution of cases in time may reflect the natural history of TB 
which is very slow branching, while contact tracing occurs at a much shorter time 
scale. Due the age limits of latent infection assessment in the past no intervention 
was possible for older contacts, but current guidelines now advocate testing for latent 
TB in all contacts under 65 (National Institute for Health and Clinical Excellence, 
2016). 
 
The median household degree of 2 reflects known UK data. Close degree was also 
very small (0-1). A minimum number of five contacts per infectious has been set as a 
quality metric for TB control boards (Anderson et al., 2014). This may be difficult to 
achieve and may not increase case detection as degree centrality did not appear to 
influence whether at least one contact developed TB disease/infection. However 
eigenvector centrality, whether a node was connected to another highly connected 
node may be more useful.  
 
There was low concordance between epidemiological links and MIRU-VNR 
relatedness as evidenced by the low sensitivity of each entity in predicting the other.  
For cases with matched genotypic data the probability that contact tracing detects an 
epidemiological link was only 2%. This is not surprising as MIRU-VNTR performs 
poorly in distinguishing relatedness for certain lineages (Sloot et al., 2013)  i.e. 
matched MIRU-VNTR isolates may in fact be unrelated. Additionally current forms 
of contact tracing are biased samples of the true contact network so not all 
epidemiological links are detected. These limitations may have contributed to 
findings in an evaluation of the national strain typing service in which it did not 
increase the contact tracing yield or reduce diagnostic delay (Mears et al., 2014). 
Thus discontinuing routine cluster investigation (search for epidemiological links 
between cases in a MIRU-VNTR cluster) as the authors suggest is supported by our 
data.  
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For cases with observed connections in the contact tracing network the probability 
that their TB isolates were genetically similar was higher at 39%. As contact tracing 
information is usually available before genotypic information, it can be a powerful 
tool in identifying transmission early. However, name-based contact tracing as 
undertaken in our study has been described to have limited utility in finding cases 
(Asghar et al., 2009). Changing the way contacts are sampled, for example repeat 
interviewing of cases, obtaining contacts of contacts ((Fitzpatrick et al., 2001; 
McElroy et al., 2003) and information about location (Gardy et al., 2011) could 
reduce transmission events.  None of these strategies have been evaluated in the UK.  
With wider experience of whole genome sequencing higher specificity in detecting 
probable transmission is expected and the number of true molecular clusters within a 
control programme is likely to reduce. This new molecular tool can only be fully 
exploited with corresponding advancements in the way contact tracing is 
programmatically done. In contrast to extensive contact tracing studies in sexually 
transmitted diseases, TB studies are lacking and more research into this area is 
needed.
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6 The largest component 
6.1 Introduction 
Many social and biological networks in the real word typically consist of many 
small, disconnected components (groups of linked individuals or nodes), but also 
strikingly a single, largest component that contains the majority of the individuals/ 
nodes (Marcotte et al., 1999; Newman, 2001; Ripeanu et al., 2002). This component 
is often termed a “giant” component, a phenomenon that has been calculated 
analytically to emerge when the number of links (edges) in a network approaches 
half the number of nodes in a network (Erdős and Rényi, 1959). In a random 
network model with a fixed number of nodes but no connections between them, if 
two nodes (not previously connected) are iteratively linked at random small chain-
like components are initially formed. If a link is formed between nodes from two 
different components, these merge into one larger component. When the average 
number of connections per node is one, the network of fragmented small components 
undergoes a phase transition to form a network where most nodes are connected to 
the giant component.  
 
In the static TB contact tracing network described in Chapter 5, cases and their 
contacts grouped into components ranging from single cases with few contacts 
through to larger structures. The largest component had 3148 individuals and 3461 
edges formed through the years 1982 to 2011. This component contained 5% of the 
individuals in the contact tracing network, and was significantly bigger than the next 
largest component (285 individuals). While existence of this largest component was 
not surprising given previous knowledge of other large scale networks, it was clearly 
unique. In particular, did its formation reflect random processes or were there critical 
events that occurred for smaller components to merge into the largest component? 
The latter would signal opportunities for intervention.
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This chapter explores the largest component in the contact tracing network in detail. 
Firstly, we describe the largest component and give an overview of its evolution with 
time. Secondly, we compare whether edge formation between nodes in the largest 
component and nodes in other components was different in terms of their number 
(per TB case and in the components overall) and cohesion (whether edges are widely 
distributed in the component or only routed through a few nodes).   Thirdly, we 
detect subgroups of nodes that were more closely clustered together and identify the 
most central nodes within the largest component, and correlate this with their 
epidemiological features to understand events that contributed to creation of the 
largest component. Finally, we attempt to ascertain the extent of disease transmission 
within the largest component by analysing available molecular epidemiology and 
contrast this with position of the nodes in the component. 
  
The largest component will be viewed as a static network only in this analysis. As 
introduced in Chapter 5, edges are considered fixed once formed although linkages 
between individuals are likely to vary with time. 
 
6.2 Objectives 
• Ascertain if infection type (diseased or latent infected) and disease extent 
(pulmonary or non-pulmonary) contributed to formation of the largest 
component. 
• Explore whether network measures (outdegree, transitivity, reciprocity and 
centrality) differed between the largest component and other components.  
• Describe the epidemiological events that occurred within and between 
subgroups of the largest component to understand what drove its formation. 
• Examine the extent to which the largest component acts to influence infection 
transmission or simply identifies a social network, by mapping available 
molecular genotyping to node position within the component. 
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6.3 Method 
The largest component is a subset of the larger contact tracing network described in 
Chapter 5. Here we note some particular aspects of the methods for readers coming 
to this chapter without detailed reading of previous chapters. 
 
All data preparation and analyses were conducted in R version 3.3.3 (R Core Team, 
2017).  
 
6.3.1 Terminology 
An infected individual refers to those with either stages of TB infection i.e. latent 
infection or active disease. Individuals were also referred to as an index case or 
contact. Contact type could be further categorised as household, close or casual. 
These terms are defined in alphabetical order in Table 18.  
 
Table 19 defines the terms used to described composition and structure of the largest 
component. These standard network terminologies were adapted from Hanneman 
and Riddle (2005). 
 
Table 20 explains the network metrics used in this chapter, as calculated in the R 
package igraph (version 1.1.2) (Csardi and Nepusz, 2006). 
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Term Definition 
Casual contact 
 
An individual not named directly by an index case but identified to be 
present at the same non-residential address at the time of the infectious 
period of the index case 
Close contact An individual named by an index case but does not reside at a mutual 
residential address 
Household 
contact 
An individual named by an index case and resides at a mutual residential 
address 
Index case An infected individual with at least one contact 
Infected Infected with either latent TB or (active) disease !Table!18.!Definition!of!terms!defining!individuals!in!the!contact!tracing!data.!
 
 
 
 
Term Explanation 
Component A set of nodes that are linked to each other by edges. 
Degree Number of edges associated with a node. 
Indegree is the number of edges the node receives. 
Outdegree is the number of edges the node sends. 
Directed edge Edges have a direction, from the case to the contact. 
Edge The relationship or link between nodes. 
Two nodes are adjacent if an edge exists between them. 
Egocentric Analysis on an individual node, with each node treated as a separate 
unit/case. 
Network The total collection of edges between nodes. Some nodes may not have 
edges to another node 
Node An individual 
Sociocentric Analysis on whole network, with each network being a separate unit/case 
Undirected edge Nodes are not classified as a sender or receiver of an edge !!!!!Table!19.!Definition!of!network!terminology!adapted!from!Hanneman!and!Riddle!(2005).!
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Term Calculation 
Component/ sociocentric level 
Assortativity 
coefficient 
The degree to which nodes associated with those similar to themselves, 
calculated according to (Newman, 2002). This coefficient ranges from -1 
to 1 with coefficients >1 denoting homophily and <1 denoting dissortative 
mixing 
Density Number of links expressed as a proportion of all possible links between 
nodes (N*(N-1)/2)  
Diameter The maximum shortest path length between any two nodes in a 
component, assuming an undirected and unweighted network. 
Clustering 
coefficient 
The number of closed triplets/the number of triplets, with edge direction 
and weights ignored. In addition components with no triplets of nodes 
were not included in the global average 
Reciprocity The number of (unordered) node pairs that had reciprocal edges divided 
by the number of (unordered) node pairs that had no edge between plus 
the number of node pairs that had non-reciprocal edges (a directed 
network was assumed) 
Node/ Egocentric level 
Adjacent Two nodes are adjacent if linked by an edge 
Betweenness 
centrality 
The sum of the number of paths that pass through it divided by the total 
number of shortest paths for each pair of nodes in the graph. This score 
was normalised by (N-1)(N-2)/2 (considering an undirected path) as the 
score scale with the number of pairs of nodes in the graph. Nodes with 
high betweenness centrality scores act as bridges between other nodes 
in the network. 
Closeness 
centrality 
The reciprocal of the average length of the shortest path between a node 
and all other nodes in the graph. Nodes with higher closeness centrality 
scores reach other nodes in the network quicker. 
Degree centrality The number of incident edges on a node, normalised by the maximum 
number of edges possible (N-1). Edge direction is ignored. 
Eigenvector 
centrality 
The weighted sum of the centrality of the nodes linked to the node in 
question. 
Shortest path 
length 
The number of edges, between a pair of nodes in a component, which 
traverses the minimal number of edges. !Table!20.!Definition!of!component!metrics!adapted!from!the!R!package!igraph!(version!1.1.2)!(Csardi!and!Nepusz,!2006).!
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6.3.2 Visualisation 
The largest component was visualised in the R package igraph (version 1.1.2) 
(Csardi and Nepusz, 2006). 
 
An individual with multiple infection events was coloured according to their earliest 
infection status only. An individual named by a case, but never infected (i.e. never 
diagnosed as a case) during the study period was coloured as a contact. Contacts who 
later became cases were coloured according to their infection status alone. For 
recurrent events, the year of the first infection diagnosis was used to label nodes, 
including if the node was a contact prior to first infection. For recurrent contacts, the 
year of the first contact only was used to label nodes. 
 
Edges in the largest component were visualised without edge direction noted when 
describing the full component to simplify the complex diagram. Edge direction was 
included when visualising the most central nodes and their subgroups to enable 
easier interpretation of the time course of epidemiological events. Edge type was 
distinguished as household, close or casual according to relationship between the 
nodes, but was not weighted. Multiple edges connecting the same two nodes (6 node 
pairs in all) were merged to a single (weighted) edge for simplification.   
 
For visualisation purposes 2,145 of 3,148 nodes whom were never cases (i.e. were 
only named as contacts) and whose removal did not disconnect the largest 
component were not displayed. This reduced representation of the largest component 
is designated as the simplified largest component.  
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6.3.3 Network metrics 
Metrics were calculated assuming a static network in the R package igraph (version 
1.1.2) (Csardi and Nepusz, 2006). Calculations were performed on the full, largest 
component i.e. with no nodes deleted, unlike the visualisation diagrams where a 
reduced network was shown (see section 6.3.2).  
 
Metrics for the largest component was compared with components of diameter 3 or 
more in the contact tracing network, i.e. medium and large components only. Small 
components of diameter 1 to 2 were excluded from comparison because their 
network measures differed from the medium and large components, as highlighted in 
Chapter 5. I will refer to the comparator, medium and large components collectively 
as other components. 
 
The Wilcoxon-rank-sum test was used to compare network metrics because values 
were not normally distributed. 
 
6.3.4 Subgroup detection 
The largest component was partitioned into groups to aid interpretation of its 
structure and evolution. The Clauset-Newman Moore algorithm was chosen as a first 
approximation due to its speed of calculation. This is a hierarchical algorithm that 
starts with each node belonging to a separate group. At each iteration of the 
algorithm two groups are merged if the modularity score improves i.e. if the 
proportion of edges within the merged group exceeds what would be expected if they 
occurred at random (Clauset et al., 2004). A node cannot belong to more than one 
group but a group can contain subgroups. The “fastgreedy.group” command in the R 
package igraph version 1.1.2 (Csardi and Nepusz, 2006), was used, with edge 
weights (whether household, close or casual relationship) ignored. When the same 
partitioning algorithm was performed on the simplified largest component, the 
number of groups reduced from 62 to 24 while maintaining nodes from known large 
contact tracing exercises within different congregate settings in the correct groups. 
Therefore groups are discussed as partitioned on the simplified largest component. 
Groups were identified by sequential letters, A – X. 
Chapter 6. The largest component 
 107 
6.3.5 Genotypic data 
As described in Chapter 5, genetic relationships between nodes were assessed using 
all 15- and 24- loci MIRU-VNTR data available. Tree-based analysis was done using 
the web application MIRU-VNTRplus (http://www.miru-vntrplus.org) which holds 
186 reference strains from all major lineages of TB. Genetic distance was calculated 
using categorical distance i.e. the number of loci with a different allele divided by 
the total number of loci (24). The default distance cutoff was 0.17, which allowed a 
difference at up to four loci. Missing loci were ignored. The neighbour-joining 
algorithm (Saitou and Nei, 1987) was used to generate phylogenetic trees. A random 
sample of 65 24-loci MIRU-VNTR sequences, which represented approximately 
20% of all available MIRU-VNTR sequences in the database, were included in the 
dendograms for reference.  The unique MIRU-VNTR sequences were identified by 
their designated national cluster name whereby prefix letters indicate the 
phylogenetic lineage followed by a unique four digit number (B for Beijing, E for 
Euro-American, C for Delhi/ Central Asian, A for East-African-Indian, X for 
multiple lineages and U for none of the recognised lineages) (Gibson et al., 2005). 
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6.4 Results 
6.4.1 Overview of the (static) largest component 
The largest component consisted of 5% (3,148/59,534) of all nodes in the study 
population. Figure 27 displays the simplified largest component. Of 3,468 edges in 
the largest component 43% (1502/3,468) were casual contact edges, 30% 
(1027/3,468) were close contact edges and 27% were household contact edges. The 
proportion of nodes that were cases (yellow and blue) was 15% (476/3,148). Eighty-
five per cent (193/228) of diseased nodes had pulmonary disease compared to 54%  
(5,100/9,495) in the overall contact tracing network (P<0.001). A relatively high 
proportion of nodes (8%, 248/3148) had latent infection compared to 4% 
(2042/51623) across the contact tracing network (P<0.001). Median age of nodes in 
the largest component was 16 (interquartile range, IQR 13 – 26) versus 29 (IQR 16 – 
49) in the whole network (P<0.05). 
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!Figure!27.!The!simplified!largest!component,!with!2,415!contact!nodes!with!only!one!incident!edge!removed.!
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6.4.2 Evolution of the largest component with time 
Figure 28 shows the growth curve for the largest component, showing the number of 
cases and contacts added each year. The timeline spanned 29 years (1982 to 2011). 
Peaks in the number of cases and contacts occurred in 2009 and 2011. There was 
also a peak in the number of contacts in 2004. I will now describe in detail the events 
that led to these larger and smaller attachments to the components. 
 
 
!Figure!28.!Number!of!cases!and!contacts!added!per!year!in!the!largest!component.!
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Growth of this component occured through two processes – the diagnosis (or re-
diagnosis) of new cases amongst existing members of the network, leading to 
addition of new contacts and possibly secondary cases and contacts and the 
identification of new cases whose contacts (or secondary cases and contacts) are 
members of the existing network. We can see the evolution of the network by 
looking at the nodes and edges of the largest component which are in the dataset 
over time (Figure 29) Prior to 2005 the largest component consisted of disparate sub-
components consisting of household/ close contact clusters.   These sub-components 
continued to grow independently, with very little linkage of existing sub-components 
until 2005, where in the top right and lower right of the picture there are some larger 
linkage events. The peak of number of new nodes in 2009 and 2011 not only 
introduced a number of new nodes, but those nodes connected the smaller subgroups 
to form the largest component (Figure 29). Casual edges formed 43% (1502/3461) of 
the edge types in the component, followed by close edges (30%, 1027/3461) and 
household edges (27%, 932/3361).  
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Figure 29. Evolution of the simplified largest component from year 1990 to 2011. 
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6.4.3 Connections in the largest component versus medium and large 
components 
The outdegree distribution of case nodes in the largest component was similar to 
case nodes in other components (Figure 30). 
 
Nodes with pulmonary disease in the largest component had a median household 
outdegree of 4 (IQR 0 – 7) versus 3 (IQR 0 – 6) in other components (P=0.12) and a 
median close outdegree of 1 (IQR 0 – 8) versus 1 (IQR 0 – 7) (P=0.34) (Figure 
30A). Nodes with pulmonary disease in both the largest and other components had a 
median casual outdegree of zero (IQR 0 – 0) (Figure 30B). The casual outdegree for 
nodes with pulmonary disease in the largest component was more distributed 
compared to other components (Figure 30C) but this difference was not statistically 
significant (P=0.31). 
 
For nodes with non-pulmonary disease the median household outdegree in the 
largest component was 4 (IQR 3 – 7) versus 3 (IQR 0 – 6) in other components 
(P=0.13) (Figure 30D). The median close and casual outdegree for nodes with non-
pulmonary disease was zero in all components with no difference in distribution 
between those in the largest component and other components (P=0.12 and P=0.61 
for close and casual outdegree respectively) (Figure 30E and Figure 30F). Very few 
nodes with latent infection in the largest and other components had any outdegrees 
(results not shown). 
 
The median indegree for respiratory case nodes in the largest component was 1 (IQR 
0 – 1) with a mean of 0.9 (SD 0.97) while those in the other components had a 
median of 1 (IQR 0 – 1) with a mean of 0.72 (SD 0.86) (P=0.01) (Figure 31A). The 
indegree distribution for non-respiratory cases in the largest component approached 
statistically significant difference when compared to other components (median 0 
(IQR 0 – 1), mean 0.37 (SD 0.65) versus median 0 (IQR 0 – 1), mean 0.62 (SD 0.77) 
in other components (P=0.05) (Figure 31B). Latent cases had similar indegree 
distributions in both the largest and other components (median 1 (IQR 0 – 1), mean 
1.3 (SD 0.51) and median 1 (IQR 0 – 2), mean 1.4 (SD 0.74); P=0.09) (Figure 31C). 
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 !!!!!!!!!!!!!!!!!!!!!!!!!!!!
!!!!!!! !!!!!!!!!! !!!!!!!!!
!!!!!!! !!!!!!!!!! !!!!!
!!!!!!! !!!!!!!!!! !Figure!30.!Outdegree!distribution!in!pulmonary!(A,!B,!C)!and!nonCpulmonary!(D,!E,!F)!nodes!in!the!largest!component!versus!536!medium!and!large!(other)!components!in!the!contact!tracing!network,!by!type!of!edge.!
A 
B 
C 
D 
E 
F 
Pulmonary case                                                        Non-pulmonary case 
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The overall density of the largest component was 6.99 x 10-4 versus a median density of 
0.12  (IQR 0.67 – 0.19) in the other components (P=0.08). Transitivity between case 
nodes in the largest component was 0.22 versus a median transitivity of 0 (IQR 0 – 
0.37), mean of 0.19 (SD 0.31) in other components (P=0.45). Reciprocity between case 
nodes was also no different in the largest component and other components (0.04 versus 
a median of 0 (IQR 0 – 0), mean 0.08 (SD 0.23); P=0.1). 
 
 
 
 
 
 
 
 
 
Figure 31. Indegree distribution in pulmonary (A), non-pulmonary (B) and latent 
case (C) nodes in the largest component versus 536 medium and large (other) 
components in the contact tracing network.  
 
Pulmonary case             
Non-pulmonary case 
Latent case 
A 
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6.4.4 Groups in the largest component 
Given the evolution of the component is driven by these independent clusters who 
are linked in later years, it is helpful to define ‘groups’ within the network, so that 
their characteristics can be defined.  
 
Figure 32 shows the static, simplified largest component with member nodes 
coloured according to their group membership. Using the Clauset-Newman 
algorithm (as described in the methods), there were 24 groups in total. These groups 
are summarised in Figure 33 where each group has been represented by a node, its’ 
size scaled according to the number of nodes in each group. Median group size was 
24 nodes (IQR 15 – 35). The largest group was group C (96 nodes) followed by 
groups H (82 nodes), B (62 nodes), D (51 nodes) and F (48 nodes). 
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!!
Figure 32. The simplified largest component grouped, in coloured polygons, as 
delineated by the Clauset-Newman algorithm. Nodes are not coloured to simplify the 
diagram. 
 
 
Chapter 6. The largest component 
 118 
!Figure!33.!The!simplified!largest!component!contracted!into!groups.!Groups!are!referenced!by!a!letter!(label).!Size!of!each!node!is!proportional!to!the!sum!of!case!and!contact!nodes!with!at!least!2!edges!in!each!group.!Edges!between!groups!were!simplified!and!do!not!reflect!the!actual!number!of!links!between!groups.!
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6.4.5 Important nodes in the largest component: centrality measures 
In order to understand which nodes acted as brokers or bridges for linkage, I first 
examined where particular nodes sit in the final static network. Figure 33 showed 
that nodes in groups C and H played a central role in connecting subcomponents of 
the largest component. This is affirmed in Table 21 which shows nodes with the 
highest centrality measures (closeness, betweenness, eigenvector and degree 
centralities) at the final timepoint. Node 12063 (group C) and node 122256 (group 
H) had very high scores for all. The node with the highest degree centrality (278) 
was node 141476 in group F (not shown in Table 19), but this node had low scores 
on other centrality measures (closeness centrality of 0.08, betweenness centrality of 
8.8 x 105 and eigenvector centrality 1.3 x 10-10).  
 
Other nodes in groups C and H that ranked highly on closeness centrality also ranked 
highly on eigenvector centrality but not betweenness or degree centrality (Table 21).  
These nodes were mutual contacts of the most central nodes (node 12063 and 
122256). 
 
Similarly, two nodes in group S (node 124648 and 129127) were mutual contacts of 
node 12064 and node 122256.   
 
A node in group X (148438) had high closeness and betweenness scores, but lower 
eigenvector scores. This node was named as a contact three times by nodes from 
communities C, I and L. 
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Node ID Group 
Closeness 
centrality Rank 
Between-
ness 
centrality Rank 
Eigen-
vector 
centrality Rank 
Degree 
centrality Rank 
12063 C 0.198 1 2.68 x 106 2 1.000 1 270 2 
122256 H 0.197 2 2.90 x 106 1 0.803 2 246 3 
148438 X 0.182 3 9.81 x 105 11 0.064 30 9 82 
133456 H 0.182 4 6.93 x 105 17 0.111 4 20 29 
124648 S 0.180 5 5.49 x 105 23 0.105 7 6 128 
133375 C 0.176 6 5.84 x 105 22 0.059 45 5 144 
129127 S 0.176 7 2.51 x 104 151 0.107 5 9 82 
148045 C 0.176 7 2.51 x 104 152 0.104 8 3 177 
149058 C 0.176 9 1.89 x 104 181 0.105 6 8 91 
149044 H 0.176 10 0 358 0.103 9 2 223 
149068 C 0.176 10 0 358 0.103 10 2 223 
148824 C 0.176 10 0 358 0.103 10 2 223 
150010 H 0.176 10 0 358 0.103 12 2 223 
148815 H 0.176 10 0 358 0.103 12 2 223 
148821 C 0.176 10 0 358 0.103 12 2 223 
149094 H 0.176 10 0 358 0.103 15 2 223 
149054 C 0.176 10 0 358 0.103 15 2 223 
148902 H 0.176 10 0 358 0.103 15 2 223 
149001 H 0.176 10 0 358 0.103 15 2 223 
149050 H 0.176 10 0 358 0.103 19 2 223 
 Table!21.!Centrality!scores!for!key!nodes!in!the!static!largest!component.!
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6.4.6 Description of groups containing the most central nodes (node 
12063, group C and node 122256, group H) 
Groups C and H play a crucial role in the development of the component, and so I 
have investigated them in more detail here. Figure 34 shows a directed subgraph for 
groups C and H, which contained the most central nodes (node 12063 circled in red 
and node 122256 circled in green). Nodes within one path length from these nodes 
and also the immediate neighbours of the first order nodes were included.  
 
6.4.6.1 Group C – a school-based super-spreading event. 
Node 12063 was a 15-year old who was symptomatic for two months while 
attending school before diagnosis of extensive cavitary pulmonary disease in 
October 2008. The case had no known prior exposure to TB, was UK-born, of Indian 
subcontinent ethnic group and had not travelled abroad in the five years prior to 
diagnosis. Contact tracing was done sequentially within the household and class 
groups of the index case but later expanded to students and school staff in the same 
year, the year above and year below the case (172 adults and 98 children aged 16 
years old and under). This large contact tracing exercise was responsible for the peak 
of individuals joining the largest component in 2009 (Figure 28). The majority of 
contacts were UK-born (72%, 195/270) and of white ethnicity (65%, 175/270).  
 
Eleven school children had evidence of incident pulmonary disease and 57 had latent 
infection (Figure 34, directed links from node 12063 circled in red).). All incident 
diseased cases were symptomatic after symptom onset in the index case. No cases 
were diagnosed in adult contacts. 
 
Four additional school children had already been treated for latent infection in the 
past after contact tracing from separate index cases, while another child had been 
treated for active disease in 1997. Figure 34 shows that many of the contacts from 
this school outbreak had a second contact episode either before or after the school 
microepidemic. 
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Molecular typing (by 24-loci VNTR) for node 12063  matched to isolates from seven 
previous cases diagnosed in 2004 and 2005, all of whom were of Black African 
ethnicity and born in a single North African country. Four of these cases could not 
be epidemiologically linked to any other case, three of whom had recently arrived 
(within five years of their diagnosis) in the UK. The remaining three cases were a 
household (parent and two children). One of these children was 16 years old at the 
time of her diagnosis with pulmonary TB in 2004 and attended the 2008 outbreak 
school. Her attendance at school did overlap with the 2008 index case’s attendance 
but no direct epidemiological links were identified. Contact tracing at the school was 
limited to 19 close friends of the 2004 case, 11 of whom completed screening with 
one latent infection case diagnosed. No further cases were diagnosed in any of these 
contacts up to the end the study period in 2011. 
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!Figure!34.!Subgraph!of!group!C!(containing!node!12063!circled!in!red)!and!group!H!(containing!node!122256!circled!in!green)!in!the!largest!component.!Labels!denote!the!year!of!diagnosis!(09=2009,!99=1999).!Nodes!who!did!not!become!cases!and!had!only!one!incident!edge!were!removed.!Only!nodes!up!to!2!(undirected)!path!lengths!away!were!included.!A!microepidemic!of!11!secondary!disease!and!57!latent!infection!cases!were!detected!on!contact!tracing.!!
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6.4.6.2 Group H 
Node 122256 in group H was a child directly linked to node 12063 in group C  
(Figure 34). Screened during the expanded school contact tracing exercise for node 
12063 in 2008, node 122256 was diagnosed and treated for latent infection in 2009 
(aged 14). In 2011 node 122256 was diagnosed with pulmonary TB following 
symptoms for four months; the TB isolate had identical by 24-loci VNTR to that of 
node 12063. This index case had previously also been exposed to TB and contact 
traced following disease in a grandparent in 1996, although the grandparent’s isolate 
had no typing information.  
 
Four household contacts were diagnosed with incident infection following contact 
tracing (disease in a 15-year old sibling and one parent, and latent infection in the 
other parent). Forty-two close, non-household contacts consisting of extended family 
and school friends were also contact traced with two further disease cases diagnosed 
(school friend and an adult) and four latent cases (three under 16s and one adult). A 
further 200 individuals (students and staff) in the same year at school were 
subsequently screened and 20 latent infection cases were diagnosis; all except one 
were in school children.  
 
Among school contacts of node 122256, two children had previously been treated for 
pulmonary TB in 2008 and 2010 respectively (Figure 34). The 2008 case (node 
154226) had self-presented with pleural TB two weeks before the diagnosis of group 
C’s index case (node 12063). Her symptoms had started two months after symptom 
onset in node 12063. She had no known TB exposure in the past and her TB isolate 
was identical to the outbreak strain. Nineteen household and close contacts were 
identified for contact tracing but none completed screening. As contact tracing for 
node 12063 was undertaken at the school not long after her diagnosis, no further 
school contacts for her were sought. 
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The second previously treated case among node 122256’s contacts occurred in 2010 
(node 152450). This student also self-presented with pulmonary TB after two 
months of symptoms and the isolate matched the outbreak strain. This student was 
not identified as a contact to group H’s index case (node 12063) in 2008. The reason 
for this is unclear as she did attend the same school in 2008. 
 
Similar to the situation in group H, school contacts of group H’s index case were 
commonly contacts again from TB cases before and after the school outbreak. 
 
6.4.7 Molecular epidemiology of the largest component 
 
Of the 223 diseased cases in the largest component, 63 (28%) had molecular typing 
information (Figure 35). Sixty-five per cent (41/63) of those with available MIRU-
VNTR typing had 15-loci data only.  
 
Genetic distances between typed nodes are shown in Figure 36. Nodes within group 
C and H (the school outbreak) were molecularly clustered together, and also were 
very close to group R (a household) and two second generation cases (L1 and I2). 
These nodes were distinct from other circulating strains in Birmingham, suggesting a 
true outbreak (Figure 37). Nodes L1 and I2 were cases that generated further large 
contact tracing exercises within a second school. Over 200 individuals were 
examined in total with 31 diagnosed with latent infection and two with disease.  
 
Three further nodes in group C (C2, C3 and C5), linked via their household contacts 
who in turn were casual contacts to the central node in group C (C1) were 
genetically further away (Figure 36). Similarly other nodes in group H (H1, H2, H3) 
were more distant both molecularly and epidemiologically to the central node in this 
group (H5). 
 
Beyond the (molecular) school cluster was a group of genetically close nodes related 
to the East-African lineage (root 4, Figure 36). These nodes were within households 
in groups F, G, I and V (Figure 35). Epidemiologically the households were linked 
by casual edges to the school outbreak. Cases occurred in different years with group 
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F in 2010, group G in 2003, group I in 2008, group V in 2003 and 2005. Another 
molecularly close node within the East-African lineage was I1, diagnosed in 2007. 
Although this node was epidemiologically linked to the central node in group H (H5) 
by a household who named both parties as close contacts (Figure 35), they were 
molecularly distant (Figure 38). 
 
A further molecular cluster within the Delhi/ Central Asian lineage was evident 
among group O nodes (Figure 40). Epidemiologically these nodes were schoolmates 
and household contacts of node O7 diagnosed in 2007 at a third school (Figure 35). 
Node D4, another genetically similar node to node O7, was diagnosed in 2011 and 
was a teacher at the same school as O7 but not a contact to him/her. A second 
teacher and student at the same school as node O7, nodes D1 and D5 respectively, 
were diagnosed in 2004. Genetically nodes D1 and D5 were further away from node 
O7’s molecular cluster (Figure 40) and therefore unlikely to have been part of the 
same transmission chain.  
 
Nodes A5, A6 and B1 genetically shared a common ancestor with nodes D1 and D5 
(Figure 40) and were epidemiologically distant (Figure 35). Nodes A5 and A6 shared 
a household. Node A6 attended a fourth school that required contact tracing at 
school, with several school contacts themselves in households affected by TB 
(Figure 35). Finally node B1 was a teacher at the outbreak school involving groups C 
and H, diagnosed in 2009, but clearly was not part of the school outbreak given the 
molecular distance between their isolates. 
 
The remainder of nodes with typing data available were less genetically clustered 
(Figure 39 and Figure 40). A minority of these nodes were in households that were 
epidemiologically close (within 2, close edge, path lengths) but genetically distant to 
nodes in other household (e.g. G2 and G1, U1 and J1, R2 and R4) (Figure 35). 
Within the same household there was one instance of genetically distant nodes (D9 
and D4).  The remainder nodes were epidemiologically linked casually to other 
nodes as expected from their genetic distance. 
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!Figure!35.!Reduced!graph!of!the!largest!component!showing!cultureCpositive!and!cultureCnegative!nodes!and!their!MIRUCVNTR!typing!availability.!All!case!nodes!were!retained!in!this!graph.!Latent!and!contact!only!nodes!were!excluded!if!they!did!not!result!in!an!increase!of!the!number!of!connected!components.!Labels!are!depicted!for!nodes!with!MIRUCVNTR!typing!information!with!the!alphabet!referencing!group!membership!(see!Figure!33)!and!unique!number!in!each!group!referencing!an!individual!node.!
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!Figure!36.!Phylogenetic!distribution!of!63!nodes!with!15C!or!24Cloci!MIRUCVNTR!sequences!in!the!largest!component.!Numbers!highlight!the!root!at!which!more!detailed!tree!analyses!was!done!with!a!sample!of!unique!MIRUCVNTR!sequences!in!the!wider!database!included!for!reference!(Figures!37!–!40).!Nodes!were!labelled!with!an!alphabet!referencing!epidemiological!group!membership!(see!Figure!33)!and!unique!number!in!each!group!referencing!an!individual!node,!and!were!coloured!according!to!their!epidemiological!group.!
1 
2 
3 
4 
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!Figure!37.!Phylogenetic!distribution!of!nodes!within!root!1!(Figure!36)!in!comparison!to!the!wider!MIRUCVNTR!sequences!in!Birmingham.!
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 Figure!38.!Phylogenetic!distribution!nodes!within!root!4!(Figure!36)!in!comparison!to!the!wider!MIRUCVNTR!sequences!in!Birmingham.!
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 Figure!39.!Phylogenetic!distribution!of!nodes!within!root!2!(Figure!36)!in!comparison!to!the!wider!MIRUCVNTR!sequences!in!Birmingham.!
 
 
Chapter 6. The largest component 
 132 
 Figure!40.!Phylogenetic!distribution!of!nodes!within!root!3!(Figure!36)!in!comparison!to!the!wider!MIRUCVNTR!sequences!in!Birmingham.!!
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6.5 Discussion 
 
The largest component differed from other components by a higher proportion of 
case nodes with pulmonary TB. Thus the largest component may have formed as a 
result of more contact tracing done overall (as non-pulmonary cases usually only 
have household contacts traced). However the proportion of case nodes with latent 
infection was also double that in the overall network. This suggests that the host 
population in the largest component was different – half of the individuals involved 
were adolescents with a median age of 16. Unlike younger children, adolescents can 
present with features of adult-type disease (most often pulmonary) as well as 
intrathoracic lymph node or extrapulmonary disease that is often seen in children 
(Cruz et al., 2013; Snow et al., 2018). They may be more susceptible to developing 
infection and disease due to altered metabolic processes associated with adolescent 
growth ((Wilcox and Laufer, 1994). In a cross-sectional survey of tuberculin skin 
test response by age groups in a high TB burden setting, the rate of acquiring latent 
TB (i.e. the force of infection) increased through childhood and reached a maximum 
at age 15 years (Wood et al., 2010). In this analysis nodes that were in a vulnerable 
age group within a congregate setting were also factors likely to have contributed to 
the size of the largest component.  
 
At the same time, the significant number of infectious nodes could enable contagion 
to spread wider and more rapidly resulting in a bigger connected component. 
However, case nodes in the largest component had similar social networks to cases 
outside the largest component. Cohesion, or how tightly linked the component was 
as measured by density, clustering coefficiency and transitivity was no different. 
Although there was some suggestion of larger households in the largest component, 
the difference was not statistically significant. Pulmonary case nodes however had 
slightly higher indegree, i.e. they were more likely to have been named as a contact 
before or after their diagnosis. This is likely a reflection of the school outbreak in 
which subsequent secondary cases resulted in repeat contact tracing of the same 
individuals within the school as there was no significant difference in the outdegree 
distribution between the largest and other components.  
 
Chapter 6. The largest component 
 134 
The community or group-finding algorithm was able to readily identify subgroups in 
the largest component that mapped correctly to epidemiological clusters of index 
cases and their concentric circle of traced contacts. When the most central nodes 
were identified it was evident that these nodes were a probable source for spread of 
infection among a susceptible school-age population, compounded by prolonged 
infectious periods. 
 
The genetic distance between nodes was underestimated in this analysis. Missing 
loci were ignored so apparent genetically close nodes may still be distant to each 
other. Nevertheless overlap of the available molecular data and epidemiological links 
in the most central nodes was highly suggestive of a superspreading event at a school 
spanning four years. At the same time molecular data enabled distinguishing several 
individuals in the school outbreak who were not part of the outbreak strain but 
involved in concurrent outbreaks in the wider community. This suggests that contact 
tracing may be identifying risk groups rather than transmission groups and the 
number of secondary cases due to the outbreak strain may have been overestimated. 
Additionally molecular data was able to highlight potential gaps in contact tracing in 
the case where molecular data matched the outbreak strain but no epidemiological 
link was confirmed. Thus mismatches of molecular and epidemiological data can 
reflect the quality or comprehensiveness of contact tracing within a TB control 
programme.  The interpretation of epidemiological and genomic data was resource 
intensive but retrospective information about exact chains of transmission or missed 
opportunities for contact tracing could inform more intelligent contact tracing in the 
future.  
 
TB in children are important markers of transmission. The burden of TB in 
adolescents and young adults in particular has only recently become a focus for 
surveillance and control (Snow et al., 2018) . School outbreaks involving 
adolescents are well reported (Watson and Moss, 2001), including the school 
outbreak described here (Caley et al., 2010). Previous cross-sectional analyses 
implied that the wider community surrounding children with TB are involved. The 
descriptive analysis of the largest component shows the extent to which this can 
occur: multiple, separate components (developing at different times over a three 
decades) were bridged by a clustering of social contacts in a school. The large 
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numbers of individuals screened at a single location was able to link in to this high 
risk network in the community more deeply than contact tracing around a single 
active case. These features may make school-based intervention where there is TB 
case efficient. At present there is no prioritisation of control activities for adolescents 
with TB in the UK. Wider epidemiological evaluation of TB in adolescents in UK 
cities is necessary to confirm whether enhanced focus on this group may be useful 
and what strategies are feasible.
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7 Measuring growth in the contact tracing network 
 
7.1 Introduction 
 
The goal of contact tracing is early detection of individuals in close proximity to an 
infectious case, among whom prevalence of disease is likely to be high. Knowledge 
of these individuals allows local control measures to limit disease spread, e.g. 
vaccination (Fenner et al., 1988), isolation (Donnelly et al., 2003) or treatment to 
prevent secondary disease or reduce the infectiousness of those already infected 
(Althaus et al., 2014). Because the formation of contact tracing networks relies on 
disease diagnosis events, i.e. each new case is in turn asked for their contacts that are 
then examined for infection, continued branching of the network suggests wider 
contagion.  
  
In chapters 5 and 6 we examined the properties of the observed static contact tracing 
network, in which the vast majority (over 90%) of linked individuals remained in 
small radial or star-like components (clusters) over time. Predicting which 
component will gain more nodes (individuals) and edges (links) may enable control 
programmes to target case finding and intervention efforts better. If component 
growth can be detected but not prevented, e.g. the epidemic of concern was already 
in a phase where multiple individuals were already infected, ability to predict 
component growth may also be useful as a monitoring tool to distinguish failure of 
contact tracing from expected discovery of infected individuals during the process.  
 
In network theory, the best-known example of how networks grow is the 
“preferential attachment” model.  In this model, nodes added sequentially to a 
network attach to nodes already in the network with a probability that is proportional  
to its degree (Barabasi and Albert, 1999; Price, 1976). This mechanism of growth 
has been shown to explain real networks that have power-law degree distributions, ie
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networks where most nodes have very few connections with only a few nodes, acting  
as hubs, being highly connected. Preferential attachment based on degree 
distribution does not intuitively explain growth of the contact tracing network as 
observed thus far – higher outdegree was not associated with increased number of 
diagnoses in contacts (Chapter 5). However the contact tracing process may not 
reveal all links and the branching topology of the network it produces may not be the 
true structure of contact between individuals. 
 
A method of explaining growth that simulates implementation of the contact tracing 
process has been explored using the Galton-Watson process. In a transmission tree of 
infected individuals where the primary infected is termed an infector and secondary 
cases arising from the infectors are termed infectees, infector/infectees can be 
discovered via contact tracing with a certain probability pc. Both infectors and 
infectees can be traced from the first generation onwards, but the primary infector 
can only be backward traced. The algorithm runs recursively over the transmission 
tree and thus discovers the size of the connected component (Muller et al., 2000). 
The minimum tracing probability required to limit the eventual component size, or 
the effective reproduction number, can then be estimated. The model relies on 
individuals being in the same chain of transmission and does not take into account 
infection from another source. However, previous investigations in Chapter 5 and 
Chapter 6 suggest that in our setting linked individuals often have different 
molecular isolates and do not always share a transmission tree.  
 
Change in longitudinal data can be empirically studied using the well-documented 
methods of survival analysis (Cox and Oakes, 1984), which focuses on if and when 
an event of interest occurs in time and how its occurrence varies with predictors; and 
individual growth modeling (Rogosa et al., 1982; Willett, 1988) or multilevel 
modeling (Goldstein, 1995), which focuses on how a dependent variable, in our 
example, size of a component, changes with time. Neither of these methods has been 
applied to explore the processes that generate networks. Nevertheless their 
familiarity makes them applicable to our problem of measuring growth in the contact 
tracing network. 
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When the contact tracing network was visualised in Chapter 5, components grew in 
diameter if infected contacts named more contacts or if separate radial/ star 
components had mutual contacts. Applying a survival approach, events causing 
component growth are a contact 1) naming a further contact, because the contact was 
diagnosed with infection  (secondary contact tracing) or 2) is named as a contact 
again by a different case (regardless of disease/infection status in the contact) 
(Figure 41). The advantage of a survival approach is that partially observed 
(censored) events are taken into account because they still contribute to the total time 
at risk until the end of the study period or individuals are lost to follow-up. This is 
particularly important because larger components were more likely to have had more 
time to evolve. Conducting time to event analysis on individual nodes clustered 
within the same component will involve repetition of analysis linked to the earliest, 
primary case (zeroth generation). Thus failure times will not be independent. 
However, marginal or frailty models can still provide consistent estimates of 
covariate effects. Node level attributes of the first generation contact and his/her 
adjacent nodes on event occurrence/timing, e.g. composition of relationship (within 
household or outside household) or demographic similarity between them can be 
examined. 
 
 
A 
 
B 
  
 
  
     
 
 
Figure 41. Examples of events causing component growth. A contact is diagnosed 
with TB and secondary contact tracing occurs (A) or a contact is named twice by 
different cases (B). Node labels denote the year of diagnosis. 
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Individual growth models can be applied to whole networks (socio-centric 
approach). This alternative method to study change in component sizes can answer 
different questions such as identifying fast- or slow-growing components and 
whether cluster-level characteristics (such as presence of recurrent cases, proportion 
of nodes born in the UK, median time delay between connected cases) determine 
growth trajectories. The main disadvantage of this approach is obtaining biased 
estimates of (individual) cluster growth due to right censoring. Furthermore 
application of growth models to contact tracing networks has not been attempted 
previously and there are no well-defined cluster-level variables. 
 
The feasibility of both approaches will be explored in this chapter. Methods and 
results will be presented separately for the node-level survival analysis followed by 
individual growth/ multilevel modeling at the component level. 
 
7.2 Objectives 
 
• Estimate the risks and factors associated with node-level events that cause 
component growth, i.e. secondary contact tracing and (outdegree from ego) 
and being named as a contact a second time (indegree from alter). 
• Quantify the risk of a TB diagnosis in a second generation contact 
• Describe the growth trajectories of components in the contact tracing network 
and explore the extent of systematic variation between components. 
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7.3 Survival analysis approach 
Data for this analysis are all cases and contacts in the Birmingham TB register 
(described in Chapter 2) with at least one edge. Growth was defined to occur when a 
contact, in a case-contact pair (the ego), developed a link to a further individual (the 
alter), by (1) naming the individual  (sending an ‘outdegree’) or (2) being named by 
the individual (receiving an ‘indegree’) (Figure 42). 
 
 
 
  
  Outdegree to alter 
 
 
 
  Indegree from alter 
 
Figure 42. Schematic depicting growth events in a network. Circles are individuals 
in the contact tracing network. 
 
 
 
Case-contact pairs were at risk for multiple events, as depicted in Figure 43. In 
particular, both ego contacts and alter contacts could be diagnosed after (forward 
traced) or prior to (backward traced) receiving an indegree or outdegree. As only 
future cases can subject to intervention, only alter events occurring forward in time 
were analysed (boxed events, Figure 43). In addition because different event types 
can occur to the same ego and were not mutually exclusive, separate one-state 
survival models were constructed for each event type.  
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Figure 43. Event histories for (directed) case-contact pairs. Blue node denotes 
backward traced case, red node denotes forward traced case. 
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7.3.1 Method 
All data for the survival approach was prepared and formatted using the R package 
Biograph (version 2.0.6) (Willekens, 2016). The package mvna (version 2.0.1) (A 
Allignol et al., 2008) was used to estimate the cumulative hazard and etm (version 
0.6-2) (Arthur Allignol et al., 2011) was used to estimate the cumulative incidence 
function. The coxph function from the survival package (version 2.42-3) was used to 
investigate the association between time to event of interest and predictor variables. 
The Efron method was used to handle ties and the robust method was used to adjust 
for egos linked in multiple case-contact pairs. Proportionality of hazards was 
examined graphically from log-log hazard plots and from Schonfield residuals. 
7.3.1.1 Terminology 
The terminology used in this chapter is consistent with previous chapters. A 
summary of terms used in this section is provided in Table 22 for reference. 
Term Definition 
Alter A node that sends or receives links or edges to an ego. 
Case/infection Infected with either latent TB or (active) disease. 
Casual edge 
 
An edge between individuals not named directly by an index case but 
identified to be present at the same non-residential address at the time of 
the infectious period of the index case 
Close edge An edge between an individual named by an index case who does not 
reside at a mutual residential address  
Degree The number of edges associated with a node. 
Indegree is the number of edges the node receives. 
Outdegree is the number of edges the node sends. 
Edge The relationship or link between nodes. 
Ego The contact in case-contact pair. Growth of the contact tracing network is 
measured by addition of links from this node.                                             
The ego is also the first generation contact. 
Household 
edge 
An edge between an individual named by an index case who resides at a 
mutual residential address. 
Index case An infected individual with at least one contact. 
Node An individual in the contact tracing network. 
Network The total collection of edges between a group of nodes. Some nodes may 
not have edges to another node. 
 
Table 22. Definition of common terms used in the survival approach to measuring 
growth in the contact tracing network. 
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7.3.1.2 Outdegree to alter 
The purpose of this analysis was to quantify the rate of second generation contact 
tracing, explore whether second generation contact tracing was associated with 
certain characteristics and quantify the risk of infection in second generation 
contacts. 
 
The initial status in this model was a case-contact pair in which the contact/ego was 
a forward-traced case. Two sequential events were subsequently of interest (1) 
outdegree to an alter (second generation contact tracing) (2) the alter being 
diagnosed as a TB case (latent infection or active disease) in the future  (risk of 
infection in second generation contact) (Figure 44). If multiple second-generation 
cases were observed, only the first (earliest in time) was considered.  
 
 
 
 
Figure 44. Transition states in a survival model to evaluate second generation contact tracing 
and its yield in case diagnosis. 
 
 
Time to an outdegree to alter was calculated from the case notification date of the 
ego. Time to case diagnosis in an alter was calculated from the time from entry into 
the first event, i.e. time from diagnosis in the ego. Follow-up was censored at the end 
of the study period (31 December 2011). 
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Edge type between the initial case-contact/ego pair, ego disease status, age, gender, 
ethnic group and birthplace and cohort (year of diagnosis in the index case) as risk 
factors for an outdegree to alter was assessed in a univariable Cox proportional 
hazards models. A multivariable model was not constructed as it was known that 
secondary contact tracing was done depending on the experience of the TB nurse 
managing the case (Catherine Brown, 2017) and a full model would not be clinically 
useful. A Cox model was also not constructed for time to case diagnosis in an alter, 
because determinants of infection following TB contact were explored in Chapter 4. 
 
7.3.1.3 Indegree from alter 
The initial state was the case-contact pair. All contacts, regardless of case status 
(forward traced case, backward traced or not a case) were considered at risk. The 
start of the follow-up time was the date the ego was registered to the case in the 
register. This time is generally after diagnosis in the case but before diagnosis in the 
ego. Follow-up was censored at the end of the study period (31 December 2011). 
Only indegrees received forward in time were considered, i.e. receiving an indegree 
after the start time. For egos receiving multiple indegrees, only the first indegree 
closest in time to the start time was included.  
 
The main variable of interest in predicting whether an indegree was received from an 
alter was the case status of the ego, as this is a clinical entity that is easily identified 
for more intensive contact tracing. Other variables assessed in a Cox model were the 
ego’s age, gender, ethnic group, place of birth and their outdegree, if they were a 
case. The type of edge (household, close or casual) between the case-contact/ego 
pair was termed the primary edge and the year of this edge formation was also 
considered. 
 
The multivariable Cox model was stratified according to first edge type between the 
case-contact pair because the hazard for this variable was not proportional over time. 
Ego’s age, gender, ethnicity and birthplace were included de novo because these 
factors were associated with the number of outdegrees (i.e. the size of their social 
circle). 
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7.3.2 Results 
7.3.2.1 Outdegree to alter 
 
Of the first generation contacts who were forward traced as a case, only 14% 
(453/3340) had second generation contact tracing (Figure 43). Thus the cumulative 
hazard for this event was low but gradually increased with time since diagnosis in 
the ego (Figure 45) corresponding to a probability of 5% at year 1 (95% CI 4.1%, 
5.6%) and 10% (95% 9.1%, 11.7%) by year 10 (Table 23). 
 
From 453 cases that had at least one second generation contact named, 131 (29%) 
had a contact that was subsequently diagnosed as case. The cumulative hazard for 
future infection diagnosis in second generation contacts was high and greatest soon 
after the exposure (Figure 45). This risk continued to increase steadily over time 
since infection in the first generation contact. Table 24 shows that if second 
generation contacts are traced there is a 28% chance (95% CI 18.7%, 37.4%) of a 
case diagnosis within two years of infection in the first generation case. This risk is 
not directly comparable to previous work that quantified the risk of infection in all 
generation contacts per TB exposure.  
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Figure 45. Nelson-Aalen estimate of the cumulative hazard for a case-case pair to 
have second generation contact tracing followed by infection in a secondary contact. 
 
Years since 
zeroth 
generation 
diagnosis 
Probability Variance Lower Upper 
1 0.05 1.41E-05 0.04 0.06 
2 0.06 1.84E-05 0.05 0.07 
5 0.08 2.59E-05 0.07 0.09 
10 0.10 4.32E-05 0.09 0.12 
15 0.11 4.32E-05 0.10 0.13 
20 0.10 9.80E-05 0.08 0.12 
 
Table 23. Probability (Aalen-Johansen estimator) for a first generation infected to have 
contacts traced. 
 
 
 
 
Years since first 
generation 
diagnosis  
Probability Variance Lower Upper 
1 0.23 2.37E-03 0.13 0.32 
2 0.28 2.27E-03 0.19 0.37 
5 0.39 2.00E-03 0.30 0.48 
10 0.52 1.60E-03 0.44 0.60 
15 0.60 1.40E-03 0.52 0.67 
20 0.67 1.50E-03 0.59 0.75 
 
Table 24. Probability (Aalen-Johansen estimator) for infection in a second 
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generation contact.  
Table 25 shows factors associated with second generation contact tracing. In the 
univariable Cox model this was more likely to occur if the ego was not a household 
contact of the index case in the zeroth generation, had disease rather than infection, 
was female, was non-UK born and was diagnosed as case later in the cohort. 
 
 
Variable Hazard 
ratio 
95% CI P 
Edge type in initial case-
contact pair (categorical) 
   
 Casual 3.31 2.45, 4.46 <0.001 
 Close 1   
 Household 0.64 0.53, 0.79 <0.001 
Ego case status    
  Latent infection 1   
 Respiratory 9.82 7.46, 12.93 <0.001 
 Non-respiratory 9.1 6.39, 12.94 <0.001 
Ego age (years) 1.03 1.03. 1.04 <0.001 
Ego gender    
 Male 1   
 Female 1.3 1.08, 1.57 <0.01 
Ego ethnic group    
 White 1   
 Black 
Caribbean 
0.8 0.53, 1.2 0.27 
 Pakistani 1.03 2.35, 3.14 0.98 
 Bangladeshi 0.74 0.4, 1.37 0.34 
 Indian 1.05 0.76, 1.43 0.77 
 Black African 0.88 0.56, 1.38 0.58 
 Other 0.44 0.22, 0.88 0.02 
 Unknown 2.125e-06 0, inf 0.98 
Ego birthplace    
 UK 1   
 Non-UK 1.27 1.05, 1.53 0.02 
 Unknown 2.424e-06 0, inf 0.98 
Year of diagnosis in ego 1 1, 1.001 <0.001 
 
Table 25. Univariable Cox regression for time to second generation contact tracing. 
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7.3.2.2 Indegree from alter 
The overall proportion of case-contact pairs extending their network by an indegree 
from an alter was 6% (3113/51,496). Figure 46 shows that indegree from an alter 
was an infrequent event with 91.5% (95% confidence interval, CI 91.1%, 91.9%) 
remaining as case-contact pairs only. Most of the risk occurred in the first five years 
after diagnosis in the zeroth generation case (five-year survival probability 96.4% 
(95% CI 96.2%, 96.5%). 
 
Table 26 shows the univariable and multivariable cause-specific hazard ratios for 
time to indegree from an alter. Case-contact pairs with a household edge were at 
increased risk of an indegree from an alter on univariable analysis. However, hazard 
estimates for the case-contact pair edge type could not be evaluated in the 
multivariable model because its hazard was not proportional over time. Of note the 
number of outdegrees from an ego was not statistically associated with the risk of an 
indegree from an alter.  
 
In the multivariable Cox model egos who became respiratory or latent cases were at 
higher risk of an indegree from a second alter compared to egos who were never a 
case (hazard ratio 1.52 and 1.16 respectively, 95% CI 1.16-1.98 and 1.16-1.93 
respectively) (Table 26). Egos who were cases in the past were not at increased risk. 
Egos’ ethnic group and birthplace remained independently statistically associated 
with risk of an indegree from an alter. Pakistani, Indian and Black African ethnicity 
had a hazard ratio of 2.96, 2.32 and 1.82 respectively (95% CI 2.21-3.95, 1.7-3.16, 
1.16-2.84 respectively) when compared to egos of White ethnicity while UK-born 
egos had 1.24 times the risk of non-UK born egos (95% CI 1.07, 1.44). 
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Figure 46. Kaplan-Meier estimator of duration remaining without an indegree from 
an alter for 51,496 case-contact pairs. Dotted lines denote 95% confidence intervals. 
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Variable Univariable Multivariable 
Hazard 
ratio 
95% CI P Hazard 
ratio 
95% CI P 
Edge type in initial case-
contact pair (categorical) 
   -   
 Casual 1.02 0.82, 1.28 0.849    
 Close 1      
 Household 1.18 1.1, 1.27 <0.001    
Year initial edge formed 1.02 1.01, 1.02 <0.001 0.99 0.98. 1.01 0.27 
Ego status       
Contact only 1      
Forward-traced infection       
  Respiratory 4.25 3.72, 4.85 <0.001 1.52 1.16, 1.98 0.002 
  Non-respiratory 3.58 2.65, 4.84 <0.001 1.14 0.81, 1.62 0.45 
 Latent 4.41 3.95, 4.93 <0.001 1.49 1.16, 1.93 0.002 
Backward-traced infection       
  Respiratory 3.98 3.07, 5.17 <0.001 1.36 0.98, 1.91 0.072 
 Non-respiratory 1.96 0.93, 4.11 0.076 0.63 0.3, 1.3 0.21 
 Latent 4.15 2.97, 5.79 <0.001 1.35 0.86, 2.11 0.2 
Ego outdegree 1 0.99, 1 0.237 -   
Ego age (years) 0.99 0.99, 1 <0.001 0.99  0.49 
Ego gender       
 Male 1   1 1  
 Female 1.04 0.97, 1.12 0.258 0.05 0.96, 1.19 0.46 
 Unknown 0.03 0.004, 0.21 <0.001 1.02 0.007, 0.36 0.003 
Ego ethnic group       
 White 1   1   
 Black Caribbean 1.31 1.03, 1.67 <0.001  0.66, 2.05 0.59 
 Pakistani 2.72 2.35, 3.14 <0.001 2.96 2.21, 3.95 <0.001 
 Bangladeshi 1.15 0.88, 1.5 0.321 1.36 0.84, 2.2 0.21 
 Indian 2.04 1.74, 2.39 0.031 2.32 1.7, 3.16 <0.001 
 Black African 1.94 1.49, 2.52 <0.001 1.82 1.16, 2.84 0.009 
 Other 1.24 0.94, 1.65 0.133 1.34 0.83, 2.18 0.24 
 Unknown 0.24 0.19, 0.3 <0.001 0.29 0.19, 0.46 <0.001 
Ego birthplace       
 UK 1   1   
 Non-UK 0.76 0.67, 0.87 <0.001 0.81 0.69, 0.94 0.005 
 Unknown 0.22 0.2, 0.25 <0.001 0.4 0.31, 0.53 <0.001 
NOTE: The hazard from edge type was not proportional with time and therefore the 
multivariable model was stratified by this variable. 
 
Table 26. Cox regression for variables associated with time to indegree from alter. 
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7.4 Growth curve model 
 
7.4.1 Method 
A multi-level framework was applied to explore how connected components grew 
over time. Growth was defined as the addition of an infected (diseased or latently 
infected) case to a component. The level-1 submodel explored the cumulative 
number of infected cases as a function of time in years since the first infected case in 
each component, represented by  
 !!" = !!! !+ !!!! !"#$!" + !ℯ!" 
where !!" the cumulative number of cases in component i at time j !!! the initial number of cumulative cases in component i !!! component i’s rate of change during the study period ℯ!"  the portion of  component i’s outcome that is unpredicted on occasion j 
 
The level-2 submodel to investigate predictors of inter-component differences in 
growth was represented by !!! = !!! !+ !!!"!"#$! + !!!! !!! = !!" !+ !!!!!"#$! + !!!! 
 
where the level-2 intercepts !!! and !!" are the population average initial number of 
cases and growth rate respectively, for a component with the reference predictor 
(PRED = 0), the level-2 slopes !!" and !!! are the effect of PRED on initial number 
of cases and growth rate for components with the reference predictor, and the level-2 
residuals !!! and ! !! are the portions of initial number of cases and growth rate that 
are unexplained at level-2. 
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The following easily observed diagnosis events in an individual (node) were 
proposed as predictors of component growth: 
• Delayed infection in a contact (i.e. more than 2 years after contact event) 
(delayed node) 
• Recurrent infection (or known previous infection) (recurrent case) 
• Recurrent contact episode (link node) 
Note that these events were not mutually exclusive in a node.  
A demographic predictor, the median age of a component was also evaluated as a 
control predictor by default because of expected association between age and the 
natural history of TB and social contact patterns. 
 
As a preliminary analysis these predictors were simplified and evaluated as non-time 
varying i.e. taken from the final static network at the end of the observation period. 
 
Models were fitted using the R package lme 4 (version 1.1-14) (Bates et al., 2015). 
Components that had only one infected case were excluded. Components were 
observed at different times (i.e. time between cases in a component was variable) 
and for different time periods and this structure was maintained in the analysis. 
Smooth non-parametric trajectories from empirical growth plots were examined. 
Because 70% of components had up to three infected cases only and had linear 
growth forms, ordinary least squares regression (OLS) was used to fit the level-1 
submodel. All other parameters were estimated using maximum likelihood. 
Association between intercepts and slopes were assessed by the Pearson correlation 
coefficient. 
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7.4.2 Results 
7.4.2.1 Empirical and parametric component growth trajectories over time 
Of 5729 separate connected components, 1417 (25%) had more than one infected 
case. Figure 48 shows the individual growth over time for these connected 
components (excluding the largest component). Seventy-one percent (1004/1416) 
had up to three infected cases and therefore had a linear growth change. However 
29% (412/1416) of the components had more than three infected cases. The growth 
trajectories for these components were more complex with periods of accelerated and 
slow growth at variable time points suggesting logistic, exponential or logarithmic 
growth forms.  Overall there was wide variation in the slopes of the different 
components, which suggested that a random slope model would be appropriate. The 
average, smooth non-parametric trajectory imposed on the empirical growth plots 
suggested that on average growth rate was highest within the first five years. 
 
Figure 47. Ordinary least squares fitted growth trajectories for components, by 
calendar year of first initial infected case. The average change change trajectory in 
for all components within each time period is shown in blue. 
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Figure 48 shows the OLS trajectories fitted to individual components. Quality of fit 
of the linear change model varied substantially between different components with 
5% (74/1416) having a low R2 statistic of 50% or less. The average initial number of 
cases in a component was 1 (intercept median -0.006, IQR -0.04, 0.1; mean 0.1, SD 
0.33).  This suggests that a model that varies by intercept may be unnecessary. The 
median estimated slope was 0.77 (IQR 0.13, 3.47) with a mean of 3.32 (SD 13.44). 
Thus on average a connected component grew by an estimated 2 cases per year. The 
correlation coefficient between the intercept and slope was -0.45 suggesting that 
components with a lower number of initial cases grew faster. 
 
When OLS trajectories were examined by calendar year of first initial case, slopes 
were flatter for those components with a longer period of observation (Figure 49). 
This agrees with the earlier observation that there is a rapid increase of component 
cases in the initial first five years followed by a period of much slower growth.
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Figure 48. Empirical and average growth trajectories of 1,416 connected 
components with more than 1 infected case in the contact tracing network. The 
largest component was excluded. The smooth, non-parametric average change 
trajectory for all connected components is shown in blue. 
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Figure 49. Linear change trajectories, residual variance and R2 statistic resulting 
from fitting separate ordinary least squares regression models for 1,416 
connected components with more than one infected case in the contact tracing 
network. The average change trajectory for all components is shown in blue. 
 
 
 
 
7.4.2.2 Exploratory analysis of relationship between component growth 
and static component predictors 
Median age, presence of a delayed diagnosis case, recurrent case and recurrent 
contact (link node) all showed an apparent effect on component growth rate 
(Figure 50). Components with a younger median age appeared to grow faster 
(Figure 50A). Slopes for components with a delayed diagnosis and recurrent case 
were less different to components without such cases but appeared worthy of 
further exploration (Figure 50B and Figure 50C). Components with link nodes or 
recurrent contacts also grew faster compared to those without link nodes (Figure 
50D). 
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7.4.2.3 Unconditional means model for component growth 
Model A in Table 27 shows the estimates from the unconditional means linear 
growth model.  The grand mean or average (log) number of cases at the start of 
component growth was 0.7 (i.e. 2 cases).  The proportion of residual variance 
due to difference between components was estimated as 0.149/(0.149 + 0.39) = 
0.28. Thus most of the variance was within each component from event (the 
addition of a case) to event (i.e. at level 1). The intraclass correlation coefficient 
interpretation of this figure is that correlation between any two events in a 
component was low. 
 
7.4.2.4 Unconditional growth model to evaluate the fixed and random 
effects of time 
Model B in Table 27 shows the effect of time in the level-1 submodel. The initial 
status in this model was 0.491 (1.6 cases) and the rate of change was 0.09 (1 case 
per event).  The level-1 residual variance reduced from 0.39 to 0.215 and the 
between-component intercept variance reduced from 0.149 to 0.069 with the 
addition of fixed and random effect of time in this model. Linear time explained 
approximately 70% of the total variability of cumulative number of cases 
(conditional R2 of 0.703). A smaller proportion of the variance accounted for by 
the fixed effect of time, 43% (marginal R2 of 0.427), was due to linear time. 
 
Given the unexplained within-component residual variance that still exists 
further predictors at level-1 should be explored. The between-component slope 
had minimal variance of 0.001 after controlling for time since the first case in a 
component. The correlation coefficient between the level 2 (between component) 
intercept and slope was high at 0.77, suggesting that the higher the initial number 
of cases the steeper the slope. 
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Figure 50. Ordinary least squares fitted trajectories for component growth, by 
levels of selected predictors. The average change trajectory for all components is 
shown in blue. 
A"
B"
C"
D"
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 Model A Model B Model C Model D 
Fixed effects 
Initial status      
   Intercept  0.711 0.491 0.7590 0.724 
   Age    -0.01 -0.011 
   Recurrent case    0.071 
   Delayed diagnosis    0.104 
   Link node    0.077 
Rate of change     
   Intercept   0.0899 0.113 0.105 
   Age    -0.001 -0.001 
   Recurrent case    -0.007 
   Delayed diagnosis    -0.005 
   Link node     0.012 
Variance components 
   Level-1 within 0.39 0.215 0.212 0.215 
   Level-2 between     
       Initial status 0.149 0.069 0.05 0.045 
       Rate of change  0.001 0.001 0.001 
       Correlation coefficient  0.77 0.72 0.87 
Goodness of fit 
Conditional !!!  0.703 0.711 0.706 
Marginal !!!  0.427 0.487 0.507 
Deviance  10994.6 8263.7 8011.6 7967.5 
AIC  11000.6 8275.7 8027.6 7995.5 
BIC  11020.3  8315.1 8080.0 8087.3 
 
Table 27. Results of fitting preliminary multi-level models of component growth. 
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7.5 Discussion 
 
This chapter has repeated some of the analyses regarding the risk of 
infection/disease following a contact but is included here due to its context for 
second generation contacts, for whom contact tracing is routinely undertaken. 
Developing a model for component growth is likely to need inclusion of time-
dependent variables which is beyond the scope of this work.
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8 Conclusions 
 
 
This work presents a systematic exploration of routine tuberculosis (TB) register 
data collected at the Birmingham Chest Clinic, UK from 1980 to 2011. Birmingham 
is an urban TB hotspot with heterogenous distribution of the disease in certain risk 
groups, an epidemiological situation typical of most low incidence countries. 
Because TB elimination is on the horizon for settings similar to the UK and 
Birmingham, there is an urgent need to find multi-modal strategies to identify cases 
and eliminate local transmission of TB. 
 
The dataset was unique in that it contained individual level information of not only 
active TB cases but those with latent infection, recorded contacts details with 
preservation of their connection to a case and spanned a long time period. The data 
were more of a census than a sample, which resulted in more descriptive than 
inferential analysis. Coding of the clinical dataset into the research dataset required 
considerable effort, with validation against clinical notes required in many cases. We 
took a conservative approach to minimize the possibility of incorrect linkage, but at 
the cost of missing links (i.e. the same individual might have many unique identifiers 
within the dataset). 
 
Identification of repeat individuals by record linkage across time was a prominent 
finding during preliminary examination of the data. The same individuals or their 
contacts appearing more than once to the clinic will be a familiar situation to 
healthcare workers, but creation of the research dataset from the Birmingham TB 
register has made the extent of this clustering and its epidemiological significance 
clearer. Once the data were created, an interdisciplinary approach combining 
traditional longitudinal research methods such as survival analysis and multilevel 
modelling with newer tools based on molecular epidemiology and network theory 
was applied.
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Use of routine data for research such as presented here has inherent limitations. 
Although the research dataset comprised near complete recording of all treated 
individuals affected by TB in the population of interest, several sources of bias exist. 
TB cases outside the geographic area were not included so repeat treatment episodes 
elsewhere and contacts out of area could not be included. Detection bias was also 
present in both case and contact data – contacts were selectively assessed for latent 
infection based on age, detected latent infection that were not treated were omitted 
and the voluntary nature of contact tracing meant that not all contacts relevant to 
exposure were named. In addition, programmatic changes to data collection and 
contact tracing have inevitably evolved over the prolonged time frame and have not 
always been documented fully. Omissions and inaccuracies in data entry further 
contributed to incomplete ascertainment of unique individuals and missing data may 
have biased the estimated effects of predictor variables. Nevertheless, evaluation of 
this real-life dataset has discovered several findings that may inform public health 
action.  
 
Three main themes have emerged from this work. Firstly, the persistence of TB with 
repeated diagnosis in individuals already treated with effective drug therapy. This is 
a recognised challenge for TB elimination. Repeated diagnosis, whether due to 
intrinsic host/pathogens factors or behavioral factors such as adherence to 
chemotherapy, have been a primary motivator for increased investment to develop 
shorter and better drug regimens (Tiberi et al., 2018). Until this is a reality, repeated 
TB episodes will contribute to the ongoing case burden and transmission. Here we 
have confirmed consistent estimates of low risk of repeated treatment episodes 
following active TB treatment in low incidence settings (Rosser et al., 2018). We 
found that latent infection treatment, additionally, contributed to retreatment cases at 
the same rate as active TB treatment. Most analyses have considered relapse from 
latent infection and active disease separately. However when projecting future case 
burden, both must be taken into account. It is unclear to what extent recording of 
latent TB infection is systematically done throughout the UK but this work supports 
its inclusion in surveillance. Recently a national initiative for testing new entrants to 
the UK for latent TB in primary care was launched in high burden areas where 
clinical commissioning allows and these cases are recorded centrally (Public Health 
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England, 2015). This is a step in the right direction but latent cases detected via other 
routes should not be missed. 
 
The second theme concerns the persistence of TB manifested through contact 
patterns that are joined into networks. TB contacts were often identified as contacts 
again due to retreatment episodes in a source case or exposure to a new case. 
Networks of linked individuals affected by TB grew through second generation 
contact tracing and separate clusters merged through a mutual case/contact due to 
new or retreatment case diagnoses. These events could be observed both near and 
distant in time to the first case diagnosis, reflecting the long natural history of TB. 
 
The first finding from examination of contact patterns was that recurrent contacts 
had twice the risk of being diagnosed as a case. Few studies combining empirical 
data and theoretical modelling have evaluated the risks of contact repetition (Al-
Mouaiad Al-Azem, 2006; Read et al., 2008; Smieszek et al., 2009) and we have 
added to the literature in this regard using a multi-state model. Recurrent contacts are 
an easily recognised clinical group who should be prioritised but their identification 
within a TB control programme requires consistent recording of unique patient 
identity. The long-term nature of TB natural history suggests that individual 
identification on the basis of address and name (given that names change and 
transcription from non-English into English is not reliable) is insufficient for this 
purpose. Health providers in England often utilise both a local identifier as well as 
the NHS number so it would be important to develop clinical systems that can 
reliably distinguish the same individual locally and nationally. 
 
We provided a description of the largest population-level TB contact network to 
date. We find that most clusters of linked individuals in the network were of small 
size and had very low density, clustering coefficient and reciprocity. This may not be 
a reflection of true social structure due to the way contact networks are formed. Thus 
no clear network measure for a case embedded in a cluster, except the eigenvector 
centrality i.e. how connected an individual was to other highly connected 
individuals, was indicative of higher number of case detection in contacts. While a 
network approach has demonstrated utility in isolated outbreaks, routine 
visualisation and measurement of network features may not be useful in identifying 
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high risk contacts or clusters in settings similar to Birmingham due to the sporadic 
nature of true outbreaks. However changing the way contacts are identified may 
produce different network structure and yield different conclusions.  
 
Within the contact patterns we found an example of a superspreading event where 
network metrics clearly identified the key players in transmission. This outbreak in a 
school setting was the catalyst in linking up over 3000 individuals who were 
previously in separate clusters within the contact tracing network. A narrative of this 
event highlighted potential gaps in its management and underlines the vulnerability 
of a susceptible population. Here the outbreak reflected a community with persistent 
burden of TB. In a declining epidemic these pockets of TB are expected to shape the 
trend of cases for the overall population (Dowdy et al., 2012). Thus the wider 
community setting in which outbreaks occur needs to be considered when making 
public health decisions because strategies in addition to traditional contact tracing 
may be required. 
 
In the third and final theme, we did not find that TB persisted when viewed from a 
molecular point of view. Although we had very limited mycobacterial repetitive 
unit-variable number tandem repeats (MIRU-VNTR) typing information for the data, 
the overall sensitivity of epidemiological links in predicting molecular links was 
only 2%. It was difficult to infer transmission due to the low resolution of the typing 
method and only partially seen epidemiological links. A recent analysis found that 
both MIRU-VNTR typing and epidemiological links based on shared household 
were poor at delineating true transmission as defined by whole-genome sequencing 
(Wyllie et al., 2018). Thus routine study of who infected whom using MIRU-VNTR 
data appears impractical outside the research setting (Munang et al., 2016).  
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Much scope exists for future work. Although contact tracing is a major strategy little 
evidence base exists regarding its practical deployment (Erkens et al., 2010). 
Qualitative studies about interview technique such as the range and number of 
questions that encourage optimal identification of individuals at risk, in what setting 
and over what time frame remain to be completed. Given that with our conservative 
linkage approach we have found continued appearance of the same people as 
contacts and cases over a period of 30 years, the identification of individuals in 
critical, as is the creation of a national system, as people frequently move between 
local health systems. 
 
Application of a multilevel model incorporating time-dependent variables would be 
worth developing to gain further understanding of the dynamics of component 
growth and know if this is preventable or if growth is simply a consequence of 
prolonged serial intervals in TB. Ultimately recommendations suggested for action 
here may benefit an individual, but which can have population level impact? 
Recurrent individuals affected by TB and larger than average groups of linked 
individuals constitute only a small fraction of the cohort and therefore interventions 
in these groups may have little consequence on the course of the epidemic. Such 
questions can be explored by modelling and the findings from this thesis could aid 
model parameterisation appropriate to our setting. 
 
In summary, analysis of a routinely collected case and contact data from 
Birmingham was able to demonstrate some useful results that have applicability to 
disease control. The findings echo known albeit recently developed core principles 
from infectious diseases modelling but translation from theory to the clinic has been 
remote. It is hoped that this work will open the door to bridging this gap.
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9 Appendix 
9.1 Case table fields in the Birmingham TB Register, 1980 - 2011 
 Field& Type& Comment& Percentage&completeness&Case&no.& Numeric& Primary&key&for&each&episode,&not&the&unique&individual&
100&
Year&of&notification& Numeric& & 100&Surname& Text& & 100&Forename& Text& & 100&Title& Text& & Not&assessed&Address&1D4& Text& & 100&(at&level&1)&Postcode& Text& & 94&Telephone&number& Numeric& & 41&Sex& Dropdown& & 100&Date&of&birth& Date& & 94&Age& Numeric& & 100&Ethnic&group& Text& & 96&Place&of&birth& Dropdown& UK&or&nonDUK& 91&Year&of&UK&entry& Numeric& & 89&Country&of&birth& Text& & 30&Previous&TB& Yes/No& & 64&Date&of&previous&TB& Numeric& New&since&2011& 3&Previous&BCG& Yes/No& & 75&BCG&scar&present& Yes/No& & 32&Date&of&BCG& Date& & 4&Occupation& Text& & 34&NHS&no.& Numeric& & 15&Hospital&no.& Alphanumeric& & 67&Other&hospital&no.& Alphanumeric& New&since&2011& 25&Consultant& Text& & Not&assessed&GP& Text& & 80&Health&visitor& Text& & 78&Risk&group& Text&Yes/No&from&2011& List&is&problem&drug&use,&currently&homeless,&been&in&prison,&drug&abuse,&alcohol&abuse&
1&prior&to&2011,&100&in&2011&
Date&of&notification& Date& & 100&Extent& Pulmonary/NonDpulmonary/&Prophylaxis& & 99&
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Organs& Dropdown& e.g.&lungs,&bone&and&joint,&gastrointestinal& 78&Smear&positive&from&which&site?& Dropdown& As&above& 29&Culture&positive&from&which&site?& Dropdown& As&above& 43&Culture&negative&from&which&site?& Dropdown& As&above& 8&Organism& Dropdown& M.#tuberculosis,#
africanum,#avium#
etc#
100&
Sensitivity& Dropdown& List&of&drugs& 40&Resistance& Dropdown& List&of&drugs& 4&Histology& Text& & 4&PostDmortem&diagnosis& Yes/No& & 59&No.&of&contacts&examined& Numeric& Calculated&from&contacts&table& 100&No.&of&contacts&treated&for&active&TB& Numeric& Calculated&from&contacts&table& 100&No.&of&contacts&treated&for&latent&TB& Numeric& Calculated&from&contacts&table& 100&CoDmorbidity&1& Text& e.g.&diabetes,&HIV,&but&also&risk&factors&e.g.&alcohol,&drug&abuse&
8&
CoDmorbidity&2& Text& As&above& 0&HIV&offered& Yes/No& Since&2011,&introduced&as&quality&metric&that&requires&reporting&
89&
Reason&not&offered& Text& & Not&assessed&Date&of&HIV&test& Date& & Not&assessed&HIV& Positive/Negative& & 55&Patient&notes& Text& & &Year&and&case&no.& Auto& Concatenated&from&year&of&notification&and&primary&case&no.&
&
Denotified& Yes/No& & 27&Symptoms&present& Yes/No& & 57&Case&status& Dropdown& List&is&denotified,&probable,&or&confirmed& 69&
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First&year&status& Dropdown& List&is&died&of&TB,&died&not&of&TB,&transferred&out,&not&known/lost&to&follow&up,&denotified,&treatment&complete,&other&problem,&culture&positive&
40&
IGRA&result& Text& Since&2011& 0&Mantoux&test&done?& Yes/No& & 58&Mantoux&size& Numeric& & 57&Treatment&start&date& Date& & 39&Treatment&end&date& Date& & 11&Date&of&symptom&onset& Date& & 18&Workplace& Text& & 6&Enhanced&tuberculosis&surveillance&(ETS)&no& Numeric& Since&2011& 100&Date&of&death& Numeric& & 2&MIRU& 12&digits& VNTR&typing& 13&MIRU_PLUS& 9&digits& VNTR&typing& 2&VNTR& 5&digits& & 11&ETR& 5&digits& & 2&
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9.2 Contact table fields in the Birmingham TB Register, 1980 - 2011 
 Field& Type& Comment& Percentage&completeness&Case&no.& Numeric& Primary&key&for&each&episode,&not&the&unique&individual&
100&
Year&of&notification& Numeric& & 100&Surname& Text& & 100&Forename& Text& & 100&Title& Text& & Not&assessed&Address&1D4& Text& & 100&(at&level&1)&Postcode& Text& & 94&Telephone&number& Numeric& & 47&Sex& Dropdown& & 98&Date&of&birth& Date& & 65&Age& Numeric& Calculated&by&program& 99&Ethnic&group& Text& & 73&Place&of&birth& Dropdown& UK&or&nonDUK& 24&Year&of&UK&entry& Numeric& & 15&Country&of&birth& Text& & 4&Previous&TB& Yes/No& & 6&Date&of&previous&TB& Numeric& New&since&2011& <1&Previous&BCG& Yes/No& & 76&BCG&scar&present& Yes/No& & 40&Date&of&BCG& Date& & 18&Occupation& Text& & 12&Relationship&to&index& Text& e.g.&cousin,&sister& 24&NHS&no.& Numeric& & 12&Hospital&no.& Alphanumeric& & 67&Consultant& Text& & Not&assessed&GP& Text& & 67&Health&visitor& Text& & 8&Comorbidity&1&and&2&& Text&& & 0&Index&case&surname& Text& & 98&Index&case&forename& Text& & 96&Index&case&year&and&case&no.& Numeric& & 88&
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Index&case&year& Numeric& & 97&Index&case&pulmonary?& Yes/No& & 98&Index&case&sputum&smear&positive?& Yes/No& & 97&Index&case&notification& Date& # 94&Index&case&close&contact?& Yes/No& & 90&Outcome& Dropdown& List&is:&OK,&fail,&prophylaxis,&BCG& 4&Workplace& Text& & <1&
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